Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer, January 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 715 articles:
HTML format


 

Single Articles

  1. SHI A, Yerebake M, Du Z, Li L, et al
    Acupuncture as adjunctive therapy for cervical cancer pain: a systematic review and meta-analysis.
    J Pain Symptom Manage. 2025 Dec 31:S0885-3924(25)01021.
    Abstract

  2. PANT S
    ACS: New Cervical Cancer Screening Guidelines.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23004.
    Abstract

  3. WANG F, Wang L, Bai Y
    Research progress of ferroptosis in cervical cancer treatment.
    Ann Med. 2026;58:2611208.
    Abstract

  4. ZHANG J, Fu C, Du J
    Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.
    Front Oncol. 2025;15:1669396.
    Abstract

  5. BUSTOS-GUTIERREZ MT, Morales-Casetti ML, Vasquez-Palma OA, Bustos-Gutierrez LR, et al
    [Social determinants of health that influence pap smear and mammography screening in Chilean women].
    Rev Salud Publica (Bogota). 2025;27:114162.
    Abstract

  6. HIRAKAWA A, Iwai N, Yanai A, Matsukawa K, et al
    Efficacy of Sentinel Lymph Node Sampling for Early Cervical Cancer: A Single Institute Study.
    J Obstet Gynaecol Res. 2026;52:e70144.
    Abstract

  7. TANG C, Jin X
    Deubiquitinating enzymes in endometrial cancer and cervical cancer.
    Gene. 2025 Dec 30:149988. doi: 10.1016/j.gene.2025.149988.
    Abstract

  8. LIU T, Zhang L, Li Y, Liao W, et al
    Glutamine metabolites promote the progression of cervical cancer by inducing M2 macrophage polarization.
    Pathol Res Pract. 2025;278:156348.
    Abstract

  9. RAJI PS, Thomas A, Thomas DS, Thomas V, et al
    Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.
    J Obstet Gynaecol India. 2025;75:461-466.
    Abstract

  10. ASFAW MS, Kassahun W
    The role of microRNAs on autophagy in cervical cancer: review.
    Discov Oncol. 2025 Dec 31. doi: 10.1007/s12672-025-04284.
    Abstract

  11. PINGAULT O, Moskal A, Bouvard C, Payet C, et al
    Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
    BMJ Open. 2025;15:e108897.
    Abstract

  12. ASARE M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al
    Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
    BMJ Open. 2025;15:e105852.
    Abstract

  13. LU X, Feng L, Zhang L, Gu F, et al
    Covalently assembled dual-functional triple-helix lentinan-Au for cervical cancer therapy.
    Carbohydr Polym. 2026;375:124799.
    Abstract

  14. TUERXUN H, Li J, Liu Q, Tursun M, et al
    MICA/B-Driven NK Cell Dysfunction Promotes Cervical Cancer via Toll Signaling.
    Exp Cell Res. 2025 Dec 29:114876. doi: 10.1016/j.yexcr.2025.114876.
    Abstract

  15. REN Y, Li S, Xiang S, Xu J, et al
    A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma.
    Cancer Med. 2026;15:e71488.
    Abstract

  16. SHARMA H, Soni KK, Thakur N, Kumar M, et al
    Intracavitary brachytherapy challenge in cervical cancer with a large cervical fibroid: A case report.
    J Cancer Res Ther. 2025;21:1431-1434.
    Abstract

  17. ABRAHAM P
    Human Papillomavirus Vaccination - A Moment of Prevention, a Lifetime of Protection.
    Indian J Public Health. 2025;69:375-376.
    Abstract

  18. KIM CA, Shelton N, Samudrala M, Savsani K, et al
    AutoEpiCollect 2.0: A Web-Based Machine Learning Tool for Personalized Peptide Cancer Vaccine Design.
    Molecules. 2025;30:4702.
    Abstract

  19. KIM MH, Yang J, Song DH, Kim CH, et al
    Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters.
    Medicina (Kaunas). 2025;61:2134.
    Abstract

  20. TERKIMBI SD, Paul-Chima UO, Mujinya R, Joan C, et al
    Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.
    Infect Agent Cancer. 2025 Dec 30. doi: 10.1186/s13027-025-00729.
    Abstract

  21. HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
    Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer.
    Anticancer Res. 2026;46:273-281.
    Abstract

  22. OOMMEN AM, Ashfaq M, Tonsing MV, Cherian AG, et al
    Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN).
    BMJ Open. 2025;15:e101599.
    Abstract

  23. ABASCAL MIGUEL L, Gaitan Barrillas R, Johnston JS, Ward V, et al
    HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.
    BMJ Open. 2025;15:e107602.
    Abstract

  24. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    Abstract

  25. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
    Obstet Gynecol Surv. 2025;80:702-704.
    Abstract

  26. MKUU RS, Tohme S, Rivero-Mendoza D, Salloum RG, et al
    Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.
    Cancer Manag Res. 2025;17:3273-3284.
    Abstract

  27. DONG S, Feng YN, Li XY, Peng YQ, et al
    An Ultrasound Radiomics Model for the Early Diagnosis of Cervical Cancer.
    Ultrason Imaging. 2025 Dec 29:1617346251403960. doi: 10.1177/01617346251403960.
    Abstract

  28. YAN Q, Zhang Z, Li R, Xue J, et al
    Clinical and nutritional-inflammatory biomarkers-based nomogram predicts survival in recurrent or metastatic cervical cancer treated with immune checkpoint inhibitors.
    Ann Med. 2026;58:2603780.
    Abstract

  29. OOMMEN AM, Ashfaq M, Viswanathan V, Singarayar P, et al
    Readiness to transition to HPV self-collection from VIA screening: a mixed methods health systems assessment from Tamil Nadu, India.
    BMC Health Serv Res. 2025;25:1619.
    Abstract

  30. ISMAEL AMEEN S, Masoudi M, Azizi H, Skutella T, et al
    HPV-Driven Immune Evasion in Cervical Cancer: Transcriptomic Identification of Downregulated Hub Genes and Suppressed Leukocyte Migration Pathways.
    Int J Mol Sci. 2025;26:12121.
    Abstract

  31. RODRIGUEZ-NAVA C, Cortes-Sarabia K, Riano-Umbarila L, Becerril-Lujan B, et al
    Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma.
    Int J Mol Sci. 2025;26:11946.
    Abstract

  32. OPLAWSKI M, Mawlichanow K, Golec-Cera A, Jedrzejczyk A, et al
    Outcomes of Cervical Cancer Treatment Using Total Mesometrial Resection (TMMR) Performed with the Robotic System-A Preliminary Report.
    J Clin Med. 2025;14:8667.
    Abstract

  33. GRIECO V, Fiorito D, Giorgianni G, Irato E, et al
    HPV Vaccine: An Effective but Underutilized Prevention Tool.
    Int J Environ Res Public Health. 2025;22:1844.
    Abstract

  34. GISCA T, Matasariu DR, Ursache A, Socolov DG, et al
    Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.
    Diagnostics (Basel). 2025;15:3231.
    Abstract

  35. JIANG Y, Wei Y, Li Z, Huang Z, et al
    Enhancing CD8(+) T Cells Infiltration Through the Protein Arginine Methyltransferase 5 (PRMT5)/CXCL10 Axis Restricts Cervical Cancer Progression.
    Biomolecules. 2025;15:1717.
    Abstract

  36. PHIANPISET R, Detwongya C, Phookiaw S, Manopunya M, et al
    Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
    Cancers (Basel). 2025;17:3960.
    Abstract

  37. SANTOS F, Caramelo FA, Tomaz JMP, Santana MM, et al
    Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2025;17:3945.
    Abstract

  38. SONG Y, Zou K, Zou L
    Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer.
    Cancers (Basel). 2025;17:3934.
    Abstract

  39. GACUTA E, Lawicki M, Grabowska H, Lawicki P, et al
    Role of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) in Diagnosing Cervical Cancer Patients.
    Biomedicines. 2025;13:2910.
    Abstract

  40. RUHODE N, Madanhire C, Tumushime MK, Gudukeya S, et al
    Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: results from serial multiple methods studies among health workers and women in Zimbabwe.
    Reprod Health. 2025;22:259.
    Abstract

  41. A AMER A, Altabbaa H, Sh Ramadan M, Abdul-Hafez HA, et al
    A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.
    Sci Rep. 2025 Dec 29. doi: 10.1038/s41598-025-30866.
    Abstract

  42. FANT C, Tewari K
    Eradicating cervical cancer in the poorest regions of the world.
    Curr Opin Obstet Gynecol. 2026;38:6-13.
    Abstract

  43. RAO S, R S, Sarma D, Nath AG, et al
    HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres?
    Asian Pac J Cancer Prev. 2025;26:4513-4523.
    Abstract

  44. BOMUANG K, Saengkhiao M, Chaimay B, Woradet S, et al
    Health Literacy and Factors Associated with HPV Vaccination among Adolescent Students: A Cross-Sectional Analytic Study.
    Asian Pac J Cancer Prev. 2025;26:4387-4396.
    Abstract

  45. SINGH N, Mangal S, Tanwar P, Singhal S, et al
    Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt.
    Asian Pac J Cancer Prev. 2025;26:4331-4338.
    Abstract

  46. LEE HY, Chipalo E, Luo Y, Chou C, et al
    Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.
    Asian Pac J Cancer Prev. 2025;26:4313-4322.
    Abstract

  47. K C BHANDARI A, Htay ZW, Parvin R, Murakami M, et al
    Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:4269-4281.
    Abstract

  48. KRYLYSHKIN M, Chernyakov A, Dil O, Truschuk J, et al
    Radical Trachelectomy Using A Titanium-Nickelide Metal Tricotage Implant to Preserve Fertility in Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2025;26:4265-4268.
    Abstract

  49. AZHARI HA, Chawdhury M, Islam F, Zakaria GA, et al
    Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.
    Front Glob Womens Health. 2025;6:1684205.
    Abstract

  50. WU X, Wang D, Mao X, Dong B, et al
    Microbiome-Driven Resistance in Cervical Cancer Therapy: From Mechanistic Dissection to Clinical Translation.
    Expert Rev Mol Med. 2025 Dec 29:1-45. doi: 10.1017/erm.2025.10029.
    Abstract

  51. BLETSAS M, Rodrigues M
    [Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy].
    Bull Cancer. 2025 Dec 27:S0007-4551(25)00534.
    Abstract

  52. ZHANG J, Zhao J, Cui RR, Wang TT, et al
    [Clinical outcomes of people with abnormal cervical cancer screening results but normal colposcopy findings].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:958-967.
    Abstract

  53. SULTANOV M, Pan F, Naheed N, Rahman A, et al
    Costing of Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda.
    Value Health Reg Issues. 2025;54:101566.
    Abstract

  54. MANGA SM, Lee GM, Ekoue N, Simeni MH, et al
    Prevalence of human papillomavirus and cervical neoplasia among women who have sex with women in Cameroon: A descriptive study.
    Afr J Reprod Health. 2025;29:122-130.
    Abstract

  55. PAKDAMAN K, Esmaeilnia Shirvani A, Pakdaman K, Karim B, et al
    Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer.
    Discov Oncol. 2025 Dec 27. doi: 10.1007/s12672-025-04255.
    Abstract

  56. ADEKUNLE TE, Adekunle TB, Thomas S
    Black Women's Perceptions of the Challenges Surrounding Cervical Cancer Screening in the United States.
    J Racial Ethn Health Disparities. 2025 Dec 27. doi: 10.1007/s40615-025-02809.
    Abstract

  57. YIN J, Zhang S, Wang S, Li Z, et al
    Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China.
    Nat Commun. 2025 Dec 27. doi: 10.1038/s41467-025-67215.
    Abstract

  58. MONTECILLO JAV, Yoo HJ, Lee YY, Park CM, et al
    Streptococcus vaginalis affects cellular dynamics of cervical cancer cells via oxidative stress-induced activation of endoplasmic reticulum unfolded protein response.
    Microbiol Res. 2025;305:128433.
    Abstract

  59. VILLARREAL XP, He R, Valle D, Kioutchoukova IP, et al
    Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.
    Cancer Causes Control. 2025;37:12.
    Abstract

  60. SULTANA F, Chatterjee N, Mukherjee D, Kumar Panda C, et al
    Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer.
    Indian J Med Res. 2025;162:493-503.
    Abstract

  61. CORREA CM, Zeferino LC, Juliato CT, Bahamondes L, et al
    Association of cervical cancer and intrauterine device use: a narrative review.
    BMC Womens Health. 2025 Dec 27. doi: 10.1186/s12905-025-04239.
    Abstract

  62. LI L, Lin D, Ao K, Zhong S, et al
    YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
    Cell Death Dis. 2025 Dec 26. doi: 10.1038/s41419-025-08188.
    Abstract

  63. TODOROVA I, Panayotova Y, Kotzeva T, Greenley R, et al
    Cervical cancer in Bulgaria since EU accession in 2007: a struggle in the face of political instability.
    Health Policy. 2026;164:105497.
    Abstract

  64. HOLDERNESS H, Kaufmann J, Erroba J, Marino M, et al
    Changes in breast and cervical cancer screening rates among Latinas after Medicaid expansion.
    Am J Prev Med. 2025 Dec 24:108241. doi: 10.1016/j.amepre.2025.108241.
    Abstract

  65. FLANAGAN M, Fantasia HC
    A Multicomponent, Team-Based Quality Improvement Project for Improving Cervical Cancer Screenings in Primary Care.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00204.
    Abstract

  66. KIM SK, Fontenot HB
    The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00211.
    Abstract

  67. AKBARI P, Ali HA, Negahi M, Frimayanti N, et al
    Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line.
    Med Oncol. 2025;43:79.
    Abstract

  68. SHAH A, Kotadia B, Padmanaban R, Patel R, et al
    Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
    Indian J Community Med. 2025;50:933-938.
    Abstract

  69. CHEN T, Zhen L, Su Y, Yi H, et al
    Nomogram for predicting urinary retention after radical hysterectomy for cervical cancer with comparative analysis of surgical methods.
    Pak J Med Sci. 2025;41:3485-3492.
    Abstract

  70. GONG P, Wang H, Wang Y
    Efficacy of laparoscopic versus open abdominal radical hysterectomy on stress response and urodynamic status in patients with early cervical cancer.
    Pak J Med Sci. 2025;41:3359-3364.
    Abstract

  71. PERELMUTER S, Balogun O
    The global need for brachytherapy innovation in cervical cancer.
    Brachytherapy. 2025 Dec 24:S1538-4721(25)00361.
    Abstract

  72. SHI Y, Zhang Z, Di X, Shen G, et al
    Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2025 Dec 23:168146.
    Abstract

  73. SHEWALKAR BK, Pant P, Patel J, Patil A, et al
    Neoadjuvant Chemotherapy Followed by Interdigitated Brachytherapy versus Standard Chemoradiation in Locally Advanced Cervical Cancer.
    South Asian J Cancer. 2025;14:404-410.
    Abstract

  74. BABU MS, Kasting ML, Rodriguez NM
    Patient attitudes toward HPV self-sampling and community health worker-delivered cervical cancer screening services in an underserved area.
    J Clin Transl Sci. 2025;9:e270.
    Abstract

  75. BEN ZUR T, Gutvirtz G, Meirovitz M, Davidesko S, et al
    [Cervical Conization and the Future Risk for Preterm Labor and Cesarean Delivery].
    Harefuah. 2025;165:627-632.
    Abstract

  76. EMON HH, Kowbi RN, Chowdhury MN, Teep TR, et al
    Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
    Sci Rep. 2025;15:44529.
    Abstract

  77. CAI L, Luo X, Wu C, Deng X, et al
    Prognostic value of ultrasonography findings in patients with cervical cancer.
    Sci Rep. 2025;15:44471.
    Abstract

  78. STRAATHOF R, Pool LI, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression.
    Brachytherapy. 2025 Dec 23:S1538-4721(25)00360.
    Abstract

  79. ASANO Y, Nishihara C, Kitayama T, Okawa N, et al
    MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.
    Acta Med Okayama. 2025;79:463-468.
    Abstract

  80. BROTHERTON JML, LaMontagne DS, Bloem PJN
    Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
    Expert Rev Vaccines. 2026;25:2609869.
    Abstract

  81. NAKASHIMA T, Matsumoto K, Yoshitake T, Kunitake N, et al
    Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.
    Jpn J Radiol. 2025 Dec 24. doi: 10.1007/s11604-025-01923.
    Abstract

  82. ZHU M, Liu J, Wang Y, Lu H, et al
    Prognostic Significance of Complete Blood Count-Derived Inflammatory Biomarkers in Patients with Small Cell Neuroendocrine Carcinoma of the Cervix.
    Curr Oncol. 2025;32:654.
    Abstract

  83. PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
    Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer - evidence from a rescue access program in Poland.
    Contemp Oncol (Pozn). 2025;29:384-392.
    Abstract

  84. LIU Z, Zhang S, Wang Y, Zong Y, et al
    Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer.
    Front Immunol. 2025;16:1662605.
    Abstract

  85. ZHOU D, Wang R, Huang L, Yan P, et al
    Real-world efficacy assessment for sintilimab in recurrent or metastatic cervical cancer.
    PeerJ. 2025;13:e20477.
    Abstract

  86. HE Q, Xiao L, Lan Y, Yao D, et al
    Analysis of the Development Trajectory and Influencing Factors of Depression in Patients With Cervical Cancer During Concurrent Chemoradiotherapy.
    Actas Esp Psiquiatr. 2025;53:1366-1374.
    Abstract

  87. FUJISAKI M, Matsumoto K
    [Latest Drug Therapies for Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:858-863.
    Abstract

  88. SHAN H, Xu Q
    Prognostic significance of pretreatment systemic immune-inflammation index (SII) in patients with cervical cancer: a meta-analysis.
    World J Surg Oncol. 2025 Dec 23. doi: 10.1186/s12957-025-04167.
    Abstract

  89. CHOPRA S, Samanta A, Nagar A, Mittal P, et al
    Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic.
    Brachytherapy. 2025 Dec 22:S1538-4721(25)00365.
    Abstract

  90. YOSHIDA-COURT K, Teka B, Cisneros Napravnik T, Karpinets T, et al
    Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.
    JCO Glob Oncol. 2025;11:e2500060.
    Abstract

  91. HUANG Q, Wang F, Li X, Zou W, et al
    Multi-omics profiling reveals an immunosuppressive plasma cell subset within tertiary lymphoid structures in cervical cancer.
    Cancer Immunol Immunother. 2025;75:26.
    Abstract

  92. KUMAR P, Ray A, Hora R, Kumari A, et al
    Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis.
    Inquiry. 2025;62:469580251399368.
    Abstract

  93. SUJAY PS, Balaji R
    GC-MS and in silico analysis reveal astaxanthin, nimbin, and gamma-sitosterol from Nyctanthes arbor-tristis flowers as dual modulators of HPV E6 and p53 in cervical cancer.
    In Silico Pharmacol. 2025;14:9.
    Abstract

  94. NAVA M, Earl J, Patel H, Canizares M, et al
    Cancer Disparities and the Political Economy of Healthcare Access: A County-Level Analysis in a High-Disparity County.
    J Prim Care Community Health. 2025;16:21501319251406402.
    Abstract

  95. PAN M, Yi T, Lei P, Mo J, et al
    Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
    J Cell Mol Med. 2025;29:e70968.
    Abstract

  96. WU X, Wang B, Liu L, Chen Z, et al
    Multi-omics analysis reveals that knockdown of IMPA2 induces apoptosis in cervical cancer cells through ROS/MYC/CDK1 signaling.
    Clin Transl Oncol. 2025 Dec 22. doi: 10.1007/s12094-025-04167.
    Abstract

  97. CHEN G, Zhang W, HuYan Y, Yang Y, et al
    Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.
    Diagn Pathol. 2025 Dec 22. doi: 10.1186/s13000-025-01744.
    Abstract

  98. MIDAKSA M, Destaw A, Getachew S, Tamrat D, et al
    Health system challenges in the diagnostic and treatment pathway for patients with suspected cervical cancer: a qualitative study.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13918.
    Abstract

  99. ZHANG L, Yang Q, Zhu H, Zheng Z, et al
    Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13871.
    Abstract

  100. MANDIWA C, Sanna M, Gao W
    Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.
    BMC Womens Health. 2025;25:603.
    Abstract

  101. ZHANG L, Fan X, Ma J, Zhang J, et al
    Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
    Nat Commun. 2025;16:11565.
    Abstract

  102. WANG J, Liu S, Li P, Negrin YP, et al
    Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer.
    Cell Death Dis. 2025;16:920.
    Abstract

  103. WANG W, Yang G, Liu Y, Wei L, et al
    Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:774.
    Abstract

  104. KIRUBA B, Raja Karthikeyan RRR, Anilkumar SR, Sundararajan V, et al
    Implications of Single-Cell RNA Sequencing in Cervical Cancer: Unravelling the Molecular Landscape.
    ACS Omega. 2025;10:60080-60093.
    Abstract

  105. HUANG C, Qiu Y, Huang X, Tang H, et al
    A digital health intervention: development and validation of a social media nursing program for sexual dysfunction following cervical cancer radical hysterectomy.
    Front Public Health. 2025;13:1720263.
    Abstract

  106. MONDAL J, Chatterjee R, Kumar Gourisaria M, Sahni M, et al
    Cervical cancer classification using a novel hybrid approach.
    Front Oncol. 2025;15:1703772.
    Abstract

  107. YAN HY, Shen XP, Tao PP, Jin L, et al
    Deep learning models for cervical cancer subtyping using whole slide images.
    Front Oncol. 2025;15:1574639.
    Abstract


  108. Retraction: MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
    Oncol Res. 2025;33:4157.
    Abstract

  109. HE G, Huang Y, Zhang X, Yuan L, et al
    Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database.
    Drug Des Devel Ther. 2025;19:11245-11257.
    Abstract

  110. CRABB K, Okwesa J, Yap JKW, Kwong FL, et al
    Challenges in managing cervical cancer in pregnancy: Three case reports.
    Case Rep Womens Health. 2025;48:e00765.
    Abstract

  111. DEWAN SMR, Proma AY, Khan SA, Meem SS, et al
    Evaluation of the Association of TNF-alpha rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case-Control Study and Meta-Analysis.
    Health Sci Rep. 2025;8:e71653.
    Abstract

  112. BERKEL C
    Radiotherapy or chemoradiotherapy might sensitize cervical cancer cells to plasma membrane rupture during necroptosis by upregulating the expression of SIGLEC12, a recently identified membrane-rupturing protein.
    Hum Cell. 2025;39:24.
    Abstract

  113. OZBAS S, Gerey S, Koc SO
    Attitudes Towards Early Diagnosis of Cervical Cancer Among Women Applying to a Health Institution in Turkey.
    J Obstet Gynaecol Res. 2025;51:e70174.
    Abstract

  114. SORMANI J, Moukam A, Wisniak A, Yakam V, et al
    Psychological and sexual impact of human papillomavirus screening in women in Cameroon: a prospective cohort study.
    BMC Womens Health. 2025;25:602.
    Abstract

  115. PEREIRA D, Almeida AM, Queiroz JA, Sousa F, et al
    Innovative minicircle DNA vector encoding pri-miR-375 silences E6 and E7 oncoproteins in HPV16-positive CaSki cells.
    Gene. 2026;981:149964.
    Abstract

  116. DHUSIYA HR, Sethy P, Pati S, Pradhan SK, et al
    How can the uptake of HPV vaccination be increased in school going girls? a qualitative study with multiple stakeholders in Ganjam, Odisha.
    Int J Adolesc Med Health. 2025;37:421-430.
    Abstract

  117. PANG D, Zhang S, Yang H, Liang K, et al
    (18)F-FDG PET radiomics for predicting progression-free survival in locally advanced cervical squamous cell carcinoma.
    Hell J Nucl Med. 2025;28:232-245.
    Abstract

  118. PEREZ BIANCHI P, Anselmo S, Vasquez Currie M, Medel J, et al
    RIVA: An Image Dataset of Conventional Pap Smear Cytology with Multiple Independent Annotations.
    Sci Data. 2025;12:1991.
    Abstract

  119. CHEN X, Wang S, Ding B, Nie Y, et al
    Dibutyl phthalate (DBP) induces cervical injury and promotes malignant transformation of cervical epithelial cells.
    Food Chem Toxicol. 2026;208:115885.
    Abstract

  120. IKEMOTO A, Uchiyama T, Takeda M, Nakamine H, et al
    Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.
    J Clin Exp Hematop. 2025;65:312-317.
    Abstract

  121. MOHAMMADI M, Fell C, Morrison D, Bell S, et al
    Cervical whole-slide images dataset for multiclass classification.
    Gigascience. 2025;14:giaf144.
    Abstract

  122. ZHU L, Wu Z, Shi S, Xue H, et al
    Dysbiosis of vaginal and peritoneal fluid microbiota in patients with cervical lesions.
    BMC Womens Health. 2025;25:631.
    Abstract

  123. FEREDE KG, Bantie B, Abdu AM, Ferede AG, et al
    Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study.
    BMC Womens Health. 2025;25:622.
    Abstract

  124. ESCOBAR V, Catalan A, Callejas V, Araya R, et al
    Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile.
    BMC Womens Health. 2025;25:617.
    Abstract

  125. CHEN M, Wu Y, Wang L, Li L, et al
    A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: A non-randomized controlled prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105280.
    Abstract

  126. BANNOUR I, Mastouri S, Bannour R, Saoudi R, et al
    HPV vaccination: analysis of acceptability among mothers - a study of 160 cases.
    Int J Adolesc Med Health. 2025;37:389-396.
    Abstract

  127. CHEN M, Li H, Wang L, Li L, et al
    Comparison of the efficacy of photodynamic therapy alone and photodynamic therapy after laser pretreatment for high-grade cervical intraepithelial lesions in women of childbearing age: a prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105260.
    Abstract

  128. SUN B, Chen Y, Cao D, Xu Y, et al
    Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomy.
    Photodiagnosis Photodyn Ther. 2025;56:105256.
    Abstract

  129. WANG X, Chen Y, Xu X, Huang J, et al
    Evaluation of the efficacy of topical photodynamic therapy against cervical HPV infection.
    Photodiagnosis Photodyn Ther. 2025;56:105250.
    Abstract

  130. YUAN S, Zhang M, Zhang C, Su Y, et al
    Effect of topical photodynamic therapy with 5-aminolevulinic acid in the treatment of high-risk cervical low-grade squamous intraepithelial lesions.
    Photodiagnosis Photodyn Ther. 2025;56:105248.
    Abstract

  131. SIERRA MS, Coto C, Porras C, Herrero R, et al
    Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
    J Infect Dis. 2025;232:e906-e915.
    Abstract

  132. HETLAND FALKENTHAL TE, Nygard S, Nygard M
    Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
    J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
    Abstract

  133. CHEN M, Guo J, Xu B
    Targeted Fluorescent Polysaccharide Platform for Solute Carrier Protein PCNA Detection and Cervical Squamous Cell Carcinoma Inhibition.
    J Fluoresc. 2025;35:11539-11552.
    Abstract

  134. CHENG E, Stubbs JM, Achat HM
    Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
    Public Health Rep. 2026;141:43-50.
    Abstract

  135. KESZTHELYI M, Sziva RE, Havran Z, Szabo V, et al
    Systemic Inflammatory Indices-Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)-As Potential Rule-Out Biomarkers for Invasive Cervical Carcinoma.
    Int J Mol Sci. 2025;27:435.
    Abstract

  136. ALVARADO-CAMACHO DA, Castillo-Velazquez R, Granados-Lopez AJ, Hernandez-Lopez H, et al
    Differentially Expressed Genes Associated with the Development of Cervical Cancer.
    Int J Mol Sci. 2025;27:258.
    Abstract

  137. WANG M, Cao Y, Zhang W, Liang Y, et al
    Prediction Model of Lymph Node Metastasis in Cervical Cancer Based on MRI Habitat Radiomics.
    Cancers (Basel). 2025;18:152.
    Abstract

  138. GORECKI G, Hale M, Taylor S, Garcia G, et al
    Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
    Cancers (Basel). 2025;18:129.
    Abstract

  139. SEMINARIO N, Bebia V, Luzarraga Aznar A, Jose MS, et al
    Postvoid Residual Volume After Radical Hysterectomy for Early-Stage Cervical Cancer: Predictive Factors and a Decision-Making Algorithm.
    Cancers (Basel). 2025;18:24.
    Abstract

  140. FAN C, Fu C
    Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    Abstract

  141. WANG S, Zhu Q, Lu Y, Yang X, et al
    Update of incidence and survival in patients with cervical cancer in the United States from 2000 to 2021.
    J Gynecol Oncol. 2026 Dec 18. doi: 10.3802/jgo.2026.
    Abstract

  142. LOVKIEL A, Petersen LK
    Increasing cervical cancer screening participation: a cluster-randomized pilot study at a department of gynaecology.
    BMC Womens Health. 2026 Jan 9. doi: 10.1186/s12905-025-04250.
    Abstract

  143. WANG L, Li X, Ren C, Liu L, et al
    Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.
    Cell Death Dis. 2026;17:24.
    Abstract

  144. LAN C, Zhang P, Zhao J, Li Q, et al
    Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.
    Cancer Discov. 2026 Jan 9. doi: 10.1158/2159-8290.CD-25-0467.
    Abstract

  145. DA SILVA LOUZA LG, de Sousa Gomes ML, Oria MOB, Rafael EV, et al
    Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.
    Cancer Causes Control. 2026;37:16.
    Abstract

  146. LIU J, Lei L, Liu Y, Wu J, et al
    Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1.
    Appl Biochem Biotechnol. 2026 Jan 9. doi: 10.1007/s12010-025-05535.
    Abstract

  147. WANG K, Si L, Zhao M, Guo R, et al
    Preoperative assessment of tumor size by MRI and ultrasound in cervical cancer: a large-scale retrospective comparative study.
    Arch Gynecol Obstet. 2026;313:23.
    Abstract

  148. ZHANG L, Mwita CJ, Soliman GA, Mushi DF, et al
    Nutritional Status of Patients Diagnosed with Cervical Cancer in Tanzania.
    Res Sq [Preprint]. 2025 Dec 18:rs.3.rs-7780798. doi: 10.21203/rs.3.rs-7780798.
    Abstract

  149. ZHANG LL, Ji YF, Li J, Wang WH, et al
    Construction of a prognostic model based on efferocytosis for predicting survival and immunotherapy efficacy in cervical cancer.
    Transl Cancer Res. 2025;14:8908-8929.
    Abstract

  150. PAI N, Rao JS
    Data-based clustering in prediction of cervical cancer DNA methylation using pan-cancer genetic and clinical data.
    Bioinform Adv. 2025;6:vbaf316.
    Abstract

  151. BEREZA K, Banas T, Grabarek BO, Czerw A, et al
    Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily on Pre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose.
    Curr Pharm Biotechnol. 2026 Jan 6. doi: 10.2174/0113892010413911251122074226.
    Abstract

  152. XIN W, Zhang J, Wu D, Cai Y, et al
    VAMP7-mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection.
    Clin Transl Med. 2026;16:e70590.
    Abstract

  153. OYARO B, Wanje G, Richardson BA, Temmerman M, et al
    A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Ke
    Implement Sci Commun. 2026 Jan 9. doi: 10.1186/s43058-025-00852.
    Abstract

  154. ZONG Y, Zhang D, Li Y, Wang P, et al
    Rare early-onset radiation-induced lumbosacral plexopathy in cervical cancer: a case report.
    BMC Neurol. 2026 Jan 8. doi: 10.1186/s12883-025-04601.
    Abstract

  155. LI F, Wei Z, Tao M, Zhao K, et al
    Notch1(+) cervical cancer cells may promote perineural invasion by secreting neurotrophin-4.
    Sci Rep. 2026 Jan 8. doi: 10.1038/s41598-025-34812.
    Abstract

  156. FAN QQ, Qin HF, Liu YQ
    Artemisinin Inhibits Drug Resistance and Epithelial-Mesenchymal Transition in Cervical Cancer Cells via the Wnt/beta-Catenin Signaling Pathway.
    Bull Exp Biol Med. 2026 Jan 8. doi: 10.1007/s10517-026-06540.
    Abstract

  157. ZHANG R, Chai S, Zhang F, Lai J, et al
    Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation.
    Cell Death Discov. 2026;12:4.
    Abstract

  158. PEPPA V, Robitaille M, Akbari F, Enger SA, et al
    Clinical test cases for commissioning, QA, and benchmarking of model-based dose calculation algorithms in (1)(9)(2)Ir HDR gynecologic tandem and ring brachytherapy.
    Med Phys. 2026;53:e70260.
    Abstract

  159. OSHIKANLU BC, Sowunmi AC, Habeebu MY, Dada AO, et al
    Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.
    Clin Med Res. 2025;23:129-136.
    Abstract

  160. FANG H, Mu J, Chow EP, Ong JJ, et al
    Chinese caregivers' preferences and predicted uptake of HPV vaccination: a study protocol for two discrete choice experiments.
    BMJ Open. 2026;16:e089565.
    Abstract

  161. VAN LONKHUIJZEN L, Mom CH, van der Aa M
    Cervical cancer in women eligible for HPV-vaccination in the Netherlands.
    J Gynecol Obstet Hum Reprod. 2026 Jan 6:103107. doi: 10.1016/j.jogoh.2026.103107
    Abstract

  162. SEEMAAB A, Colaizzi A, Matsko J, Ye Y, et al
    Assessment of microorganism detection in ThinPrep Papanicolaou tests utilizing the Hologic Genius Digital Diagnostics System.
    Am J Clin Pathol. 2025;164:946-952.
    Abstract

  163. GANGULY AP, Pretsch PK, Brewer NT, Spees LP, et al
    Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus: A Single-Group Secondary Analysis of a Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551345.
    Abstract

  164. KITAMI K, Kuji S, Kamiya N, Machida H, et al
    Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study.
    Int J Clin Oncol. 2026 Jan 8. doi: 10.1007/s10147-025-02951.
    Abstract

  165. MURUGAIYAN K, Srivastava R, Balaraman J, Eswar K, et al
    Gold-Coated Glybosomes Mimicking Physiological Micelles for ROS-Mediated Photothermal Ablation against Cervical Cancer.
    ACS Appl Bio Mater. 2026 Jan 8. doi: 10.1021/acsabm.5c02289.
    Abstract

  166. OLTHOF EP, Oostveen NA, van der Aa MA, Bekkers RLM, et al
    Prognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
    Gynecol Oncol Rep. 2025;63:102002.
    Abstract

  167. JURJUT O, Weiss M, Daniel Y, Matovina S, et al
    Detection of Cervical Intraepithelial Neoplasia Using Hyperspectral Tissue Signatures.
    IEEE J Transl Eng Health Med. 2025;13:532-539.
    Abstract

  168. SINNO AK, Mustapha A, Nair N, Zaami S, et al
    Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives.
    Oncol Res. 2025;34:4.
    Abstract

  169. JIANG C, Rosenberg PS, Jemal A, Sung H, et al
    Cervical cancer incidence rates by birth cohort against the backdrop of human papillomavirus vaccination in the United States.
    J Natl Cancer Inst. 2026 Jan 7:djaf374. doi: 10.1093.
    Abstract

  170. LU R, Zhang J, Ma X, Feng Y, et al
    Dual-dimensional profiling of host genomic variations and HPV integration in PD-L1-stratified cervical cancer via Oxford Nanopore Technology.
    J Transl Med. 2026 Jan 7. doi: 10.1186/s12967-025-07674.
    Abstract

  171. PATEL MS, Patel KS, Willmann J, Feliciano EJG, et al
    Cervical cancer screening beyond traditional barriers.
    Lancet Public Health. 2026;11:e6.
    Abstract

  172. MEGLIC E, Ploner A, Clements M, Elfstrom M, et al
    Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: a population-based cohort study in Sweden.
    Lancet Public Health. 2026;11:e35-e43.
    Abstract

  173. LI H, Ahmad M, Zhou D
    Relaxin-2 Inhibits Cervical Cancer Growth by Downregulating Kruppel-Like Factor 5 (KLF5) Through the Inhibition of Hippo-YAP and JAK2/STAT3 Signaling Pathways.
    J Biochem Mol Toxicol. 2026;40:e70687.
    Abstract

  174. KABIR SF, Ashik-Ur-Rahman M, Rahman A, Hossen MA, et al
    Factors Associated With Low Utilization of Cervical Cancer Screening Services in Gazipur, Bangladesh.
    Obstet Gynecol Int. 2025;2025:4476955.
    Abstract

  175. ROMANOVA M, Klat J
    Prognostic significance of L1CAM in cervical cancer: A narrative review.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2026.
    Abstract

  176. SOLTAU CP, Sinha D, Patil LP, Moseley PM, et al
    Redox-active nitroxides enhance cisplatin efficacy against cervical cancer.
    Redox Biol. 2025;89:103989.
    Abstract

  177. YUAN K, Bai Y, Chen S, Shi Y, et al
    The effects of earthworm fibrinolytic enzyme on cervical cancer Caski cells based on CiteSpace and VOSviewer visual analysis.
    Medicine (Baltimore). 2026;105:e46783.
    Abstract

  178. ZHAI J, Pang T, An Y, Wang J, et al
    Clinical significance of CXCL17 in cervical cancer.
    Medicine (Baltimore). 2026;105:e46178.
    Abstract

  179. HERNANDEZ A, Burrowes S, Gelaw B, Abede T, et al
    Is there a difference in sample adequacy when vaginal HPV DNA samples are self-collected at home, a health post, or a primary care health center in rural Ethiopia? Implications for community cervical cancer screening.
    BMC Womens Health. 2026 Jan 7. doi: 10.1186/s12905-025-04226.
    Abstract

  180. ALHMEID EK, Aldohni AAA, Alghanim AI, Salha RM, et al
    Sociodemographic Determinants of Cervical Cancer Screening among Ever-Married Women in Jordan: Insights from the 2023 Jordan Population and Family Health Survey.
    J Epidemiol Glob Health. 2026;16:5.
    Abstract

  181. LIU R, Liang L, Wang J, Wang M, et al
    Optimization of Liquid-Based Cytology Block Preparation Using Modified Adhesive Centrifugal Sedimentation for Improved Diagnostic Accuracy in Cervical Lesions.
    APMIS. 2026;134:e70131.
    Abstract

  182. NANDAKUMAR V, Krishnan S, Chang CP, Yee S, et al
    High-risk human papillomavirus genotype prevalence in Singapore cervical samples: Implications for clinical management.
    Ann Acad Med Singap. 2025;54:758-765.
    Abstract

  183. SURMAVA S, Kvaratskhelia E, Davitashvili B, Vardiashvili N, et al
    Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women.
    Cancer Control. 2026;33:10732748251413338.
    Abstract

  184. MA LL, Yang SJ
    [Mucosal melanoma with atypical EWSR1 break-apart signal arising in the cervix and vagina: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:93-95.
    Abstract

  185. CHRISTINE B, Bush M, Thurakal A, Sheehy AM, et al
    New Cervical Cancer Screening Guidelines From the US Department of Health and Human Services: Strengthening Women's Preventive Health.
    JAMA. 2026 Jan 5. doi: 10.1001/jama.2025.26456.
    Abstract

  186. PENG D, Zhang A, Zhang Y
    Bridging digital divides: A quantitative assessment of equity, access, and determinants of AI adoption for women's reproductive cancer care in China.
    Afr J Reprod Health. 2025;29.
    Abstract

  187. YUAN H, Wang X, Liu K, Zhang J, et al
    Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
    Int J Womens Health. 2025;17:5719-5731.
    Abstract

  188. QIAN XF, Wang XW, Yi HQ, Li LF, et al
    Peritoneal Post-Radiation Angiosarcoma in a Patient With a History of Radiation for Cervical Cancer.
    Am J Case Rep. 2026;27:e949701.
    Abstract

  189. GONG Y, Wu J, Hu Y
    m(6)A epitranscriptomic regulation of KRAS by METTL3 promotes EMT and stromal remodeling through TGF-beta/SMAD signaling in cervical cancer.
    Cancer Gene Ther. 2026 Jan 3. doi: 10.1038/s41417-025-00993.
    Abstract

  190. LIU X, Guo L, Zhang H, Xue L, et al
    Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer.
    Int Immunopharmacol. 2026;171:116128.
    Abstract

  191. SABEENA S, Beynon C
    The Impact of the COVID-19 Pandemic on HPV Vaccination Coverage Among Adolescents From High-Income Countries and Challenges: A Scoping Review.
    Rev Med Virol. 2026;36:e70102.
    Abstract

  192. WU Y, Wei B, Wei Z, Wang H, et al
    Single-cell and spatial transcriptomic profiling reveals distinct tumor microenvironment dynamics in cervical adenocarcinoma and squamous cell carcinoma.
    Commun Biol. 2025;9:46.
    Abstract

  193. CHATTERJEE R
    Sexual assault and cancer pathways: a scoping review of biomedical and screening outcomes.
    BMC Womens Health. 2025;26:16.
    Abstract

  194. ABUDUREXITI G, Muhetaer K, Yang J, Zhuo Q, et al
    HPV vaccine knowledge gaps and vaccination intent: a cross-sectional study of vocational students in Southern Xinjiang of China in 2023.
    BMC Public Health. 2025;26:102.
    Abstract

  195. CALFA S, de Freitas AJA, Causin RL, Hirai W, et al
    Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions.
    Sci Rep. 2025;16:828.
    Abstract

  196. GETIE B, Wondimu E, Almaw A, Legese B, et al
    Prevalence and risk factors of high-risk cervical HPV infections among women attending Debre Tabor hospital family planning and gynecology clinic, Northcentral Ethiopia.
    Sci Rep. 2025;16:779.
    Abstract

  197. LAM MCY, Mbogo BW, Plaunt E, Mukankaka S, et al
    Transport stipend to facilitate cancer early detection: experiences of beneficiaries and perspectives of program personnel in Rwanda.
    BMC Public Health. 2025;26:13.
    Abstract

  198. ALIZADEH L, Keshavarz Z, Shalbaf A, Iranpour S, et al
    Iranian women's perceptions of human papillomavirus and barriers to vaccination: a qualitative study based on the health belief model.
    BMC Public Health. 2025;26:5.
    Abstract

  199. LIU Y, Han Z, Kaminski P, Tao C, et al
    Topoisomerase IIalpha orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication.
    Virol Sin. 2025;40:946-961.
    Abstract

  200. KHASTGIR G, Saha PK, Bagga R
    From hesitancy to hope: charting India's path to widespread HPV immunisation.
    Eur J Contracept Reprod Health Care. 2026;31:53-58.
    Abstract

  201. BROSHKEVITCH CJ, Pretsch PK, Spees LP, Wheeler SB, et al
    Underscreened Women's Reactions to At-Home Self-Collected Human Papillomavirus Test Result Delivery.
    Sex Transm Dis. 2026;53:109-115.
    Abstract

  202. KOBAYASHI M, Nakagawa S, Ishii Y, Kamei Y, et al
    VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix.
    Cancer Sci. 2026;117:78-89.
    Abstract

  203. ICHINOHE D, Umehara Y, Fujita H, Yamauchi Y, et al
    [A Case of Laparoscopic Lateral Segmentectomy for Metachronous Liver Metastasis from Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:1053-1054.
    Abstract

  204. YANG W, Liu S, Shang D, Liu P, et al
    Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription.
    BMC Mol Cell Biol. 2026 Jan 16. doi: 10.1186/s12860-026-00566.
    Abstract

  205. LI C, Lin H, Zhang H
    Transcriptomic profiling of T cell exhaustion mechanisms in cervical cancer pathogenesis.
    Discov Oncol. 2026 Jan 16. doi: 10.1007/s12672-026-04423.
    Abstract


  206. HPV vaccine could help to protect the unvaccinated against cervical cancer.
    Nature. 2026 Jan 16. doi: 10.1038/d41586-026-00128.
    Abstract

  207. BOSE S, Mandal R, Sengupta S, Dutta S, et al
    Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting.
    BMJ Glob Health. 2026;11:e021707.
    Abstract

  208. ULMER KK, Soltani LF, Addis I, Young AP, et al
    Major changes in cervical cancer screening in the US.
    Prev Med. 2026 Jan 14:108512. doi: 10.1016/j.ypmed.2026.108512.
    Abstract

  209. TOES-ZOUTENDIJK E, Arbyn M, Auvinen A, Baldwin D, et al
    European Code Against Cancer, 5th edition - organised cancer screening programmes.
    Mol Oncol. 2026;20:134-153.
    Abstract

  210. OKUNADE KS, Soibi-Harry A, Fayinto AI, Adelabu H, et al
    Effect of Socioeconomic Status on Cervical Cancer Screening Behaviour Among Mothers of Adolescent Girls in Lagos, Nigeria: A Secondary Analysis of the mHealth-HPVac Study.
    Res Sq [Preprint]. 2026 Jan 9:rs.3.rs-8126074. doi: 10.21203/rs.3.rs-8126074.
    Abstract

  211. PAKDEL T, Kargar M, Farhadi A, Aghdaei MH, et al
    MCPyV small T antigen enhances HPV16 oncogene expression, promotes Ca Ski cell proliferation, and reduces 5-fluorouracil-induced apoptosis in cervical cancer cells.
    Infect Med (Beijing). 2025;4:100222.
    Abstract

  212. JIA Y, Zhang F, Zou K, Zou L, et al
    Corrigendum to "A Clinical Study on the Efficacy of Concurrent Chemoradiotherapy Combined with Targeted Therapy and Hyperthermia in Patients with Locally Advanced Cervical Cancer" [Translational Oncology,Volume61, November 2025, 102516].
    Transl Oncol. 2026;64:102656.
    Abstract

  213. ESTUPINAN RUIZ CA, Morales Doncel RD, Hincapie-Carvajal JA
    [Public health and cervical cancer in Latin America: the impact of health spending and legislation on prevention in three countries].
    Aten Primaria. 2026;58:103427.
    Abstract

  214. ZAHIROVA N, Tillyashaykhov M, Egamberdiev D, Lucas E, et al
    Lessons Learned From Evaluation of a Human Papillomavirus Screening Pilot in Uzbekistan.
    JCO Glob Oncol. 2026;12:e2500250.
    Abstract

  215. ZHANG J, Feng J, Yin C, Dong Z, et al
    The Impact of Anesthesia and Surgical Intervention on Liver and Kidney Function in Patients With Gynecological Malignancies.
    Ann Ital Chir. 2026;97:175-184.
    Abstract

  216. VAN NOORTWIJK R, Kroon PS, van Vliet-van den Ende KM, Brondijk EH, et al
    Dosimetric comparison between brachytherapy and MR-Linac as a boost modality for locally advanced cervical cancer.
    Clin Transl Radiat Oncol. 2025;57:101098.
    Abstract

  217. MISZCZYK M, Wu T, Kuna K, Stankiewicz M, et al
    Corrigendum to "Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials". [Clin. Translat. Radiat. Oncol. 47 (2024) 100801].
    Clin Transl Radiat Oncol. 2025;56:101057.
    Abstract

  218. LAN T, Yao X, Zhou X, Shi L, et al
    [Clinicopathological Characteristics of Cervical Neuroendocrine Carcinoma and Their Relationship With Prognosis].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:1633-1640.
    Abstract

  219. ZHENG Z, Sun S, Zhu J, Jiang Q, et al
    Relationship Between Intestinal Flora and Acute Radiation Enteritis in Patients With Advanced Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    Adv Radiat Oncol. 2025;11:101968.
    Abstract

  220. YING Z, Shi M, Gong W, Chen Y, et al
    g(E)-pHLIP promote virus immunity to destroy cervical cancer cell.
    Eur J Med Res. 2026 Jan 14. doi: 10.1186/s40001-025-03787.
    Abstract

  221. AMANKWAH I, Gone M, Jaliu A, Morand M, et al
    Breast and cervical cancer care in Ghana: a qualitative exploratory study of stakeholder perspectives on National Health Insurance Scheme coverage.
    BMJ Open. 2026;16:e098784.
    Abstract

  222. PILLAY J, Gates A, Guitard S, Zakher B, et al
    Correction: Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care.
    Syst Rev. 2026;15:9.
    Abstract

  223. SU X, Wu H, Chen X, Ouyang Y, et al
    Comparison of efficacy and safety of definitive chemoradiotherapy for cervical cancer patients of different age groups using propensity score matching.
    Discov Oncol. 2026 Jan 13. doi: 10.1007/s12672-026-04392.
    Abstract

  224. WUBINEH BZ, Rusiecki A, Halawa K
    Deep learning-based automatic segmentation and classification for cervical cancer detection using an improved U-Net and ensemble methods.
    Sci Rep. 2026 Jan 13. doi: 10.1038/s41598-026-35299.
    Abstract

  225. BHENGU P, Wiysonge CS, Magasana V, Cooper S, et al
    Healthcare workers' and caregivers' knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu-Natal Province, South Africa.
    Hum Vaccin Immunother. 2026;22:2613571.
    Abstract

  226. RAECK J, da Silva JB, Carvalho L, Salgado L, et al
    Endothelial dysfunction markers in cervical cancer and their influence on patient outcome.
    Mol Biol Rep. 2026;53:283.
    Abstract

  227. XUE L, Zhou S, Tang L, Li G, et al
    EM2, a Novel Elephantopus mollis H.B.K. Monomer, Enhances Radiosensitivity in Cervical Cancer Through Dual Inhibition of AKT and Autophagy.
    FASEB J. 2026;40:e71454.
    Abstract

  228. CHENG L, Guo C, Yang Y
    Correlation and combined predictive value analysis of serum IL-6 and IL-10 levels with tumor progression in patients with cervical cancer.
    Eur J Med Res. 2026 Jan 12. doi: 10.1186/s40001-025-03791.
    Abstract

  229. CAO Z, Yang S, Zou J, Jin Y, et al
    CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis.
    Apoptosis. 2026;31:41.
    Abstract

  230. YUAN L, Wen B, Li X, Liu F, et al
    Development and validation of a risk prediction model for overall survival in cervical cancer patients under 50: a prospective cohort study in southwest China.
    PeerJ. 2026;14:e20509.
    Abstract

  231. ZHOU Y, Cheng S, Shu L, He W, et al
    Quercetin-Fe nanodots inhibit cervical cancer cell proliferation by targeting PCNA.
    Cancer Nanotechnol. 2026;17:2.
    Abstract

  232. FENG H, Yoshida E, Sheng K
    Multimodality and temporal analysis of cervical cancer treatment response.
    Quant Imaging Med Surg. 2026;16:78.
    Abstract

  233. RAMOS-PIBERNUS A, Bermonti-Perez M, Mejias-Serrano D, Moreta-Avila F, et al
    Development of a Culturally Sensitive Intervention for Cervical Cancer Screening Promotion for Latinx Transgender Individuals.
    Cancer Med. 2026;15:e71494.
    Abstract

  234. BECK JB, Morenz AM
    Updates in Cervical Cancer Screening: A Practical Guide for the Internist.
    Am J Med. 2026 Jan 9:S0002-9343(26)00014-8. doi: 10.1016/j.amjmed.2025.
    Abstract

  235. BLAZEJCZYK I, Daniluk T, Toczylowski K, Gorbacz-Kononczuk J, et al
    Antimicrobial peptides in cervical carcinogenesis: Dual roles in tumor progression and emerging therapeutic strategies.
    Biomed Pharmacother. 2026;194:118928.
    Abstract

  236. NONBOE MH, Napolitano G, Schroll JB, Andersen B, et al
    Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study.
    Vaccine. 2025;73:128142.
    Abstract

  237. GUO S, Lin H, Chen Y, Hu Q, et al
    A study on strategies to optimize bladder volume consistency in radiotherapy patients.
    Eur J Med Res. 2025;31:81.
    Abstract

  238. LI Y, Zhao J, Li M, Cheng Y, et al
    Xiaoyou decoction suppresses cervical precancerous lesions through the activation of cellular autophagy and the upregulation of p53 expression.
    Int J Biochem Cell Biol. 2026;191:106894.
    Abstract

  239. ZHANG Y, Yan L, An N, Geng J, et al
    TFF3 sensitizes cervical carcinoma cells to cisplatin toxicity by binding to IGF2R.
    Cancer Gene Ther. 2026;33:155-168.
    Abstract

  240. DUSHKIN A, Maxim A, Oxana S, Stanislav A, et al
    Effect of photodynamic therapy on the expression of toll-like receptor 2, -3, -4, and -8 in the cervical lesions.
    Photochem Photobiol. 2026;102:141-153.
    Abstract

  241. KWEK ME, Ang JX, Mathur M, Kho LCL, et al
    Comparison of awareness, attitudes and knowledge on human papilloma virus vaccination in Singapore: 2019 versus 2013.
    Singapore Med J. 2025;66:596-600.
    Abstract

  242. MADHAVAN Y, Muthukumar V, Ramasubramanian S, Ramshankar V, et al
    High throughput HPV genotyping by next generation sequencing for detection of 28 HPV types and 13 sexually transmitted infections: A first community-based cervical cancer screening study from India.
    Diagn Microbiol Infect Dis. 2026;114:117278.
    Abstract

  243. NGUANBOONMAK A, Pakkaranang B, Yanaranop M, Tantiyavarong P, et al
    Incidence trends and survival of cervical cancer: A population-based study on Thai Cancer registry database.
    Cancer Epidemiol. 2026;101:102992.
    Abstract

  244. GROVER S, Chambers A, Azoba C, Bhatia RK, et al
    Overcoming Logistical Barriers to Conducting Collaborative Clinical Research Between a High-Income Country and a Low- and Middle-Income Country.
    JCO Glob Oncol. 2026;12:e2400534.
    Abstract

  245. AHMED B, Sayeed S, Rhodes C, Shahab G, et al
    The Virginia Commonwealth University Cervical Cytology Biorepository: A Protocol for Advancing Translational Cervical Cancer Research through Biobanking.
    Cancer Epidemiol Biomarkers Prev. 2026.
    Abstract

  246. KIM U, Bae J, Paik ES, Lim MC, et al
    Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028).
    J Gynecol Oncol. 2026 Jan 8. doi: 10.3802/jgo.2026.
    Abstract

  247. KIM J, Jang J, Kang S
    Patient-centered valuation of minimally invasive surgery in cervical cancer: a discrete choice experiment.
    J Gynecol Oncol. 2025 Dec 29. doi: 10.3802/jgo.2026.
    Abstract

  248. BABATUNDE AO, Kokelu E, Olusanya OA, Kalulu P, et al
    Creative Arts to Enhance Cervical Cancer Awareness Using Art-Based Messages From a Nigerian Crowdsourcing Open Call: Qualitative Thematic Analysis.
    JMIR Form Res. 2026;10:e76240.
    Abstract

  249. YI K, Zhang J, Wang H, Chen P, et al
    Utility of extended HPV genotyping in cervical cancer screening: a prospective population-based cohort study in China.
    Front Oncol. 2026;15:1754438.
    Abstract

  250. YANG H, Xu F, Liu Y, Chen Q, et al
    Pelvic artery embolization versus vaginal packing for controlling vaginal bleeding in locally advanced cervical cancer: a retrospective cohort study from a tertiary cancer center in Xinjiang, China.
    Front Oncol. 2026;15:1711701.
    Abstract

  251. MUTUA F, Dube S, Shrivastav A, Kakumanu S, et al
    Cervical Cancer Outcomes and Toxicity in HIV-Positive Women Treated With Radiation or Chemoradiation: A Systematic Review.
    Cureus. 2025;17:e99855.
    Abstract

  252. SHAN X, Si J, Qian M, Chen X, et al
    Revealing relationships: The role of self-disclosure and marital intimacy in the post-traumatic growth of cervical cancer patients-A qualitative study.
    Support Care Cancer. 2026;34:121.
    Abstract

  253. LIN X, Piao Z, Huang X, Huang H, et al
    Inter-fraction target and OARs reproducibility in cervical cancer: Influence of immobilization systems and patient positioning verified by daily fan beam CT.
    Radiography (Lond). 2026;32:103328.
    Abstract

  254. SATO S, Kagabu M, Jo A, Otsuka H, et al
    Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.
    Int J Clin Oncol. 2026 Jan 22. doi: 10.1007/s10147-026-02960.
    Abstract

  255. CIHAN E, Pirincci CS
    The efficacy of complex decongestive therapy in the treatment of lymphedema associated with endometrial and cervical cancer: evaluation of sensation and balance.
    Support Care Cancer. 2026;34:113.
    Abstract

  256. HARADA I, Ito Y, Morita K, Kawahara M, et al
    Associations Between Regional Factors and Cervical Cancer Screening Coverage in Tokyo.
    Asian Pac J Cancer Prev. 2026;27:281-285.
    Abstract

  257. HANGA AH, Amin S, Iqbal A, Shah A, et al
    Between Belief and Biology: Cervical Cancer's Occurrence and Health Literacy among India's Muslim Women.
    Asian Pac J Cancer Prev. 2026;27:219-226.
    Abstract

  258. MOHD NAFIS NS, Mat Zin AA, Ab Hamid SA
    Assessment of Pathtezt(R) Infinity Processor and Autoloader Efficiency in Cervical Smear Analysis.
    Asian Pac J Cancer Prev. 2026;27:193-199.
    Abstract

  259. LATTASAKSIRI P, Prasongvej P, Chanthasenanont A, Boriboonhirunsarn D, et al
    Knowledge and Attitudes of Pregnant Women toward Cervical Cancer Screening during Pregnancy.
    Asian Pac J Cancer Prev. 2026;27:117-121.
    Abstract

  260. GEORGA D, Saridi M, Rouka E, Fradelos EE, et al
    Exploring Women's Attitudes Towards Cervical Cancer Screening and Their Association with Life Satisfaction and General Life Attitudes: A Systematic Review.
    Asian Pac J Cancer Prev. 2026;27:37-46.
    Abstract

  261. JIANG R, Zheng J, Lin X, Wang S, et al
    EGF Family-Based Prognostic Model Reveals AREG as a Key Regulator in Cervical Cancer Progression.
    Curr Med Chem. 2026 Jan 9. doi: 10.2174/0109298673397451251105070115.
    Abstract

  262. DING L, Li S, Jin Z, Yao C, et al
    The impact of body composition and systemic inflammatory markers on postoperative complications in early-stage cervical cancer.
    Front Oncol. 2026;15:1696383.
    Abstract

  263. YAMAZAWA Y, Iijima T, Shigenaga D, Cho T, et al
    Rapid enlargement of a tubo-ovarian abscess in a patient with cervical cancer and multiple uterine fibroids: A case report.
    Case Rep Womens Health. 2026;49:e00784.
    Abstract

  264. ZOU D, Wu X, Xin X, Xu T, et al
    Correction to: Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes.
    Reprod Sci. 2026 Jan 21. doi: 10.1007/s43032-026-02053.
    Abstract

  265. ZHANG YJ, Yan L, Chen YY, Jiang X, et al
    A nomogram-based prediction model for assessing the risk of vain and stump cancer recurrence following radical surgery for cervical cancer.
    Discov Oncol. 2026 Jan 21. doi: 10.1007/s12672-026-04462.
    Abstract

  266. ZHANG Y, Zhang Y, Wang K
    EP300 promotes cervical cancer progression through a Wnt/beta-catenin-dependent HIF-1alpha signaling axis.
    Toxicol Appl Pharmacol. 2026 Jan 19:117718. doi: 10.1016/j.taap.2026.117718.
    Abstract

  267. JIANG H, Cai J, Shen Z, Xu M, et al
    UniCAS: A foundation model for cervical cytology screening.
    Cell Rep Med. 2026;7:102570.
    Abstract

  268. SPARKES NK, Adcock A, Slater T, MacDonald EJ, et al
    'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer prevention.
    J Prim Health Care. 2026 Jan 22. doi: 10.1071/HC25164.
    Abstract

  269. KOIVISTO T, Eriksson T, Hokkanen M, Apter D, et al
    Human papillomavirus vaccinations' association to childbirth rates.
    Hum Vaccin Immunother. 2026;22:2598691.
    Abstract

  270. WANG W, Zhang J, Mei C, Dai Q, et al
    Prevalence and genotype distribution of human papillomavirus infection among women in Chengdu, China between 2020 and 2024.
    Front Public Health. 2026;13:1740177.
    Abstract

  271. BAO T, Li X, Li W, Yang R, et al
    Integrated multi-omics profiling of plasma extracellular vesicles reveals the hsa-miR-1-3p-LRP1 axis as a potential biomarker in cervical cancer.
    Mol Clin Oncol. 2025;24:13.
    Abstract

  272. GROSS M, Wang JY, Goff BA, Ma TM, et al
    Treatment delay and prolongation in locally advanced cervical cancer.
    Gynecol Oncol Rep. 2025;63:102004.
    Abstract

  273. WEBB S, Mat Ali N, Augustin Y, Hayward SE, et al
    Understanding knowledge, beliefs, values and barriers towards cervical cancer screening and self-sampling amongst migrant Muslim women in Southwest London: an in-depth qualitative interview study.
    BMJ Public Health. 2026;4:e003254.
    Abstract

  274. AKISEKU AK, Adenuga TO, Jagun OE, Popoola MA, et al
    Individual-level determinants of late-stage cervical cancer diagnosis and their implications for prevention and control.
    Ecancermedicalscience. 2025;19:2008.
    Abstract

  275. OLAYIWOLA AA, Oshodi YA, Akinola OI, Banjo AA, et al
    High-risk HPV serotype distribution in cervical cancer: comparative analysis of detection in cervicovaginal secretions and tissue DNA extraction.
    Ecancermedicalscience. 2025;19:1992.
    Abstract

  276. ADENEKAN MA, Minari JB, Adefemi A, Olorunfemi G, et al
    Comparison analysis of serum interleukin-6 levels and cervical cancer.
    Ecancermedicalscience. 2025;19:2009.
    Abstract

  277. CHHABRA M, Meet S, Tendulkar G, Oswal K, et al
    Barriers to screening of breast and cervical cancer among women in remote villages of Karnataka: an analysis using the Health Belief Model.
    Ecancermedicalscience. 2025;19:1980.
    Abstract

  278. SAMIA K, Yassine B, Mehdi SE, Wissal H, et al
    Psychosocial impact of cervical cancer diagnosis: a study conducted in the Radiotherapy Department at CHU Hassan II, Fez, Morocco.
    Ecancermedicalscience. 2025;19:1976.
    Abstract

  279. KIBUDDE S, Kavuma A, Abal B, Katumba MF, et al
    Radiation therapy for cervical cancer in Uganda: a practice guideline.
    Ecancermedicalscience. 2025;19:1999.
    Abstract

  280. WANG L, Zhu J, Ding Z, Xie Z, et al
    Immune Predictors of Radiotherapy Outcomes in Cervical Cancer.
    Adv Sci (Weinh). 2026 Jan 21:e09784. doi: 10.1002/advs.202509784.
    Abstract

  281. ZHANG Y, Meng Y, Shi H, Li L, et al
    Prevalence and influencing factors of depressive and anxiety symptoms in cervical cancer patients during the peri-chemoradiotherapy period: A systematic review meta-analysis.
    Medicine (Baltimore). 2026;105:e47023.
    Abstract

  282. JIA H, Arifu A, Wang J, Fan P, et al
    SPP1 enhances radiotherapy resistance through CCL2-mediated M2-like polarization of macrophages in cervical Cancer.
    Int Immunopharmacol. 2026;172:116119.
    Abstract

  283. CHANG Y, Li T, Zhou Q, Kang D, et al
    Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population.
    Obstet Gynecol Surv. 2026;81:24-25.
    Abstract

  284. SAPKOTA A, Adhikari C, Kaphle HP, Bist BB, et al
    Effectiveness of health education interventions for cervical cancer screening: A quasi-experimental study in Pokhara Metropolitan Slum, Nepal.
    PLOS Glob Public Health. 2026;6:e0005853.
    Abstract

  285. HUANG Z, Luo Y, Gao Q, Wang L, et al
    Novel N(6)-methyladenosine (m(6)A) writer METTL16 promotes the cervical cancer tumorigenesis by targeting FTH1-dependent ferroptosis.
    Discov Oncol. 2026 Jan 20. doi: 10.1007/s12672-026-04403.
    Abstract

  286. INOUE T, Iijima K, Takatsu J, Murakami N, et al
    Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer.
    Radiol Phys Technol. 2026 Jan 20. doi: 10.1007/s12194-026-01007.
    Abstract

  287. ZHANG J, Wei W
    Re-examining the lymph node surgical strategies for small-cell cervical cancer: shifting from local intervention to a systemic paradigm.
    Int J Surg. 2026 Jan 20. doi: 10.1097/JS9.0000000000004649.
    Abstract

  288. AHMED AE, Hatan WM, Alrehaili SE, Alghamdi WR, et al
    Interventions in Primary Care to Improve Cervical Cancer Screening: A Systematic Review.
    Cureus. 2025;17:e99604.
    Abstract

  289. XIE H, Li J, Huang H, Emmanuel A, et al
    SOX1/PAX1 Methylation for Triage of HPV-Positive Women in Cervical Cancer Screening: A Cohort Study.
    BJOG. 2026 Jan 19. doi: 10.1111/1471-0528.70162.
    Abstract

  290. LI Y, Xin R, Chai P, Liu B, et al
    Economic evidence for expansion of HPV vaccination for the prevention of cervical cancer in LMICs: BIA framework construction and empirical analysis in China.
    BMC Public Health. 2026 Jan 19. doi: 10.1186/s12889-026-26216.
    Abstract

  291. GAO M, Cui Z, Song H, Li Y, et al
    IRF4 Enhances Radiosensitivity of Cervical Cancer by Inhibiting the PI3K/Akt/mTOR Pathway to Regulate Autophagy.
    Cancer Sci. 2026 Jan 19. doi: 10.1111/cas.70305.
    Abstract

  292. WONG SIAW LIN C, Ghosh A, Bhardwaj N, Zouridis A, et al
    Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasia.
    BMJ Case Rep. 2026;19:e270886.
    Abstract

  293. FOKOM DEFO V, Fokom Domgue J
    Understanding the WHO global strategy to accelerate cervical cancer elimination.
    Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00004.
    Abstract

  294. AMANI A, Bloem P, Kobayashi E, Atuhaire B, et al
    Understanding the WHO global strategy to accelerate cervical cancer elimination - Authors' reply.
    Lancet Glob Health. 2026 Jan 16:S2214-109X(26)00011.
    Abstract

  295. PEI Y, Zhong Z, Li H, Tan Y, et al
    Targeting thymidylate synthase enhances CD8 + T-cell infiltration and inhibits tumor growth in cervical cancer.
    Med Oncol. 2026;43:120.
    Abstract

  296. NAMUTUNDU J, Nakku-Joloba E, Kiguli J, Makumbi F, et al
    "Correcting Misinformation is Challenging": Exploring Barriers and Facilitators of Health Care Providers' Responsiveness to Cervical Cancer Screening Literacy Needs of Rural Women Living With HIV in Eastern Uganda.
    Cancer Control. 2026;33:10732748261419591.
    Abstract

  297. CAI X, Lu X, Yang J, Wei X, et al
    Diagnostic value of magnetic resonance imaging in preoperative evaluation of cervical cancer and analysis of pathological features.
    Oncol Lett. 2026;31:96.
    Abstract

  298. ENYAN NIE, Zhang M, Ken-Amoah S, King-Okoye M, et al
    Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low- and Middle-Income Countries.
    Biomed Res Int. 2026;2026:9294978.
    Abstract

  299. BASERA A, Alaouna M, Duvenhage J, Bates DO, et al
    HPV-driven transcriptome and splicing rewiring under SRPK1 inhibition in cervical cancer.
    Front Oncol. 2026;15:1712170.
    Abstract

  300. FOKOM DOMGUE J, Al-Antary N, Gerend MA, Nair M, et al
    Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020.
    Hum Vaccin Immunother. 2026;22:2610894.
    Abstract

  301. TIMALSINA G, Parida BP, Radhakrishnan M, Khoiyang T, et al
    Falcarindiol induces apoptosis, ROS accumulation, and cell cycle arrest via EGFR/mTOR pathway modulation: an integrated in silico and in vitro study in cervical cancer.
    Daru. 2026;34:7.
    Abstract

  302. AL-MUTAIRI SH, Akhtar S
    Age at first marriage, menopause status and cervical cancer risk in a middle eastern country: a national cancer registry-based case-control study.
    Cancer Causes Control. 2026;37:18.
    Abstract

  303. OOMMEN AM, Ashfaq M, Ranjani DP, Suresh D, et al
    Leveraging the role of families in decision-making to inform a program of HPV-based self-collection for cervical screening in Tamil Nadu, India: a qualitative study.
    Cancer Causes Control. 2026;37:25.
    Abstract

  304. SU Q, Duan H, Li Q, Zhang M, et al
    Galectin-1-Targeted Type-I/II Photosensitizers Activate the NF-kappaB Pathway to Enhance Immunity and Treat High-Risk HPV-Associated Cervical Lesions.
    ACS Appl Mater Interfaces. 2026;18:3599-3614.
    Abstract

  305. RAY-COQUARD I, Kaminsky-Forrett MC, Ohkuma R, de Montfort A, et al
    Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.
    Nat Commun. 2026;17:922.
    Abstract

  306. LU Q, Li J, Gao X, Wu B, et al
    Folic acid inhibits the Wnt/beta-catenin pathway by upregulating DKK3 to exert anti-tumor effects in cervical squamous cell carcinoma.
    Sci Rep. 2025;16:2930.
    Abstract

  307. LI J, Huang CB, Zhao F, Zhao DD, et al
    Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study.
    Virol J. 2025;23:13.
    Abstract

  308. MWAENI V, Nyamai D, Khamadi S, Musenjeri S, et al
    Multimodal detection of high-risk HPV oncogenic transcripts using a branched hybridization chain reaction amplification method.
    Anal Methods. 2026;18:293-305.
    Abstract

  309. IZQUIERDO-CONDOY JS, Torres PL, Galarza MO, Salinas KA, et al
    Prevalence and age-related trends of high-risk Human Papillomavirus genomes in Ecuadorian women: a comprehensive cross-sectional study.
    BMC Infect Dis. 2025;26:83.
    Abstract

  310. AKALIN K, Cicek Gumus E, Dolu I
    Cancer screening knowledge and health literacy among rural women Aged 30-69.
    Cancer Epidemiol. 2026;100:102971.
    Abstract

  311. CHIN T, Ostrbenk A, Verhavert N, Poljak M, et al
    Multi-centre clinical validation of the NeuMoDx HPV assay for ASC-US / LSIL triage.
    Diagn Microbiol Infect Dis. 2026;114:117208.
    Abstract

  312. STOLNICU S
    Role of human papillomavirus status in the classification, diagnosis, and prognosis of malignant cervical epithelial tumors and precursor lesions.
    Pathologie (Heidelb). 2026;47.
    Abstract

  313. CHARBEL A, Akiki G, Diwan SS, Leung SOA, et al
    Small cell neuroendocrine carcinoma of the cervix: diagnostic challenges and emerging molecular insights(dagger).
    J Pathol. 2026;268:123-126.
    Abstract

  314. YANG XL, Zhu JW, Zhou YC, You Y, et al
    Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study.
    Int J Surg. 2026;112:1274-1283.
    Abstract

  315. SAHOO GR, Sah AN, Srivastava M, Panigrahi PK, et al
    In Vivo Cervical Precancer Classification Through Multifractal Analysis of Spectral Fluctuations in Intrinsic Fluorescence Spectra.
    J Biophotonics. 2026;19:e202500282.
    Abstract

  316. KIRKPATRICK CE, Lawrie LL
    "This is What a Speculum Looks Like!" Effects of Medical Instrument Demonstration and Message Framing in Pap Test Videos on Social Media.
    Health Commun. 2026;41:278-289.
    Abstract


  317. Retraction: miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
    Oncol Res. 2026;34:30.
    Abstract

  318. PANDIT SK, Sen B, Kumar P, Tripathi A, et al
    Anti-cervical cancer potential of apigenin, daidzein, and isokaempferide of Glycyrrhiza glabra Linn. Methanolic extract via network pharmacological analysis.
    In Silico Pharmacol. 2026;14:44.
    Abstract

  319. ANUPAMA CV, Devarapalli D, Ahammad SH, Eid MMA, et al
    Cervical cancer cell prediction and detection with high test accuracy based on a reliable automated system.
    3 Biotech. 2026;16:83.
    Abstract

  320. KHORRAMABADI SM, Ebrahimi N, Aghbash PS, Ravanlo ZZ, et al
    Silencing HPV: the rise of RNA therapeutics in cervical cancer.
    Infect Agent Cancer. 2026 Jan 29. doi: 10.1186/s13027-026-00733.
    Abstract

  321. UMEMIYA M, Kou K, Inayama Y, Kamei J, et al
    Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Jan 29. doi: 10.1007/s10147-026-02968.
    Abstract

  322. ZENG L, Chen Z, Wang K, Yi C, et al
    Epidemiology and prevention of HPV-driven cervical cancer in urban-rural China: a population-based study of 60,280 women.
    Sci Rep. 2026;16:3937.
    Abstract

  323. ELFSTROM KM, Dillner J
    Towards faster, better, and cheaper cervical cancer screening.
    Lancet Public Health. 2026;11:e72-e73.
    Abstract

  324. SULTANA F, Smith M, Saville M, Bateson D, et al
    Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study.
    Lancet Public Health. 2026;11:e101-e110.
    Abstract

  325. XIAO FY, Ma RC, Wang YX, Zhou JW, et al
    [Value of self-sampling cervical exfoliated cells of HPV E6/E7 mRNA detection in cervical cancer screening: a multicenter clinical study].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:60-66.
    Abstract

  326. YUAN M, Hong Y, Feng Y, Sun J, et al
    Cervical Cancer Incidence and Mortality Trends in China: The role of Screening.
    Cancer Lett. 2026 Jan 27:218286. doi: 10.1016/j.canlet.2026.218286.
    Abstract

  327. BALE CA, Pearce JV, Deng X, Bandyopadhyay D, et al
    Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study.
    Arch Gynecol Obstet. 2026;313:66.
    Abstract

  328. GU X, Yang Y, Zhang Z, Ouyang Y, et al
    Long Non-Coding RNA RAB11B-AS1 Suppresses Cervical Cancer Progression by Upregulating RPL26 Expression.
    Front Biosci (Landmark Ed). 2026;31:47597.
    Abstract

  329. WU Z, Huang C, Li R, Li H, et al
    Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.
    Front Oncol. 2026;16:1765010.
    Abstract

  330. WANG Z, Zhang H, Zhu Y, Jiang Y, et al
    Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females.
    Front Immunol. 2026;16:1747082.
    Abstract

  331. NGUYEN AT, Duckworth ED, Li RA, Adam TH, et al
    Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2026 Jan 28. doi: 10.1002/jso.70200.
    Abstract

  332. GENNARI P, Luft D, Meszaros J, Ignatov A, et al
    Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients.
    Arch Gynecol Obstet. 2026;313:65.
    Abstract

  333. ASEFA T, Endale HT, Mengstie TA, Getnet M, et al
    Determinants of cervical cancer screening among women living with HIV in Lesotho using nationally representative 2023/24 DHS data.
    Sci Rep. 2026 Jan 28. doi: 10.1038/s41598-026-37180.
    Abstract

  334. KULJARUSNONT S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, et al
    Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study.
    Cancer Control. 2026;33:10732748261422014.
    Abstract


  335. Correction to "Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline".
    CA Cancer J Clin. 2026;76:e70066.
    Abstract

  336. JIA X, Da X, Shi J, Wang Y, et al
    Digital health interventions for cervical cancer screening among hard-to-reach women in health-resource-limited areas: Protocol for a controlled trial with historical controls and two randomised intervention arms.
    Digit Health. 2026;12:20552076261416317.
    Abstract

  337. ZHUANG Q, Liu Y
    Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2026;16:1729380.
    Abstract

  338. KONDLO S, Giyose N, Businge CB, Mbulawa ZZA, et al
    Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa.
    Viruses. 2025;18:65.
    Abstract

  339. CINTONI M, Autorino R, Rinaldi RM, Leonardi E, et al
    Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy: Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC).
    Nutrients. 2026;18:312.
    Abstract

  340. DAVID LL, Singh M
    Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model.
    Pharmaceuticals (Basel). 2025;19:74.
    Abstract

  341. HUSSAIN SS, Maisam M, Younas S, Wang F, et al
    From Functional Food to Therapeutic Prospect: Mechanistic Study of Gypenoside XVII in HeLa Cells.
    Molecules. 2026;31:214.
    Abstract

  342. PATINO-MORALES CC, Jaime-Cruz R, Gonzalez-Perez R, Villavicencio-Guzman L, et al
    The Chick Embryo Chorioallantoic Membrane Assay as a Short-Term Exploratory Model for Cervical Cancer Research.
    Life (Basel). 2026;16:135.
    Abstract

  343. TOROMANI G, Saglimbeni GS, Upadhyayula BS, Manu E, et al
    Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.
    Medicina (Kaunas). 2026;62:123.
    Abstract

  344. GORGULU G, Sanci M
    Perspectives from Hysterectomy Specimens on the Hidden Malignancy Risk in HSIL Patients with Surgical Margin Continuity.
    Medicina (Kaunas). 2025;62:77.
    Abstract

  345. IBIS K, Aydin MH, Kokce K, Suncak L, et al
    The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?
    Medicina (Kaunas). 2025;62:14.
    Abstract

  346. SEMENOV DV, Tatarnikova IS, Chesnokova AS, Talyshev VA, et al
    Single-Cell Transcriptomic Landscape of Cervical Cancer Cell Lines Before and After Chemoradiotherapy.
    Cells. 2026;15:115.
    Abstract

  347. LEGAKI E, Lappa T, Prasoula KL, Kardasi Z, et al
    HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.
    Int J Mol Sci. 2026;27:803.
    Abstract

  348. LAGUNAS-CRUZ MDC, Valle-Mendiola A, Soto-Cruz I
    The Vaginal Microbiome and Host Health: Implications for Cervical Cancer Progression.
    Int J Mol Sci. 2026;27:640.
    Abstract

  349. MARTINEZ-RAMIREZ I, Munoz-Bello JO, Contreras-Paredes A, Parra-Hernandez E, et al
    Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer.
    Int J Mol Sci. 2026;27:591.
    Abstract

  350. KIM J, Jang J, Tewari KS, Kim KS, et al
    Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea.
    Cancers (Basel). 2026;18:346.
    Abstract

  351. DU M, Zheng Z, Lu P, Wang W, et al
    Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer.
    Cancers (Basel). 2026;18:320.
    Abstract

  352. KARNIK M, Tulimilli SV, Anantharaju PG, Bettadapura ADS, et al
    An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.
    Cancers (Basel). 2026;18:318.
    Abstract

  353. MAREMA TP, Laka K, Mbita Z
    Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer.
    Biology (Basel). 2026;15:191.
    Abstract

  354. EMADI SH, Ahmad S, Rahmanian M, Baharlou R, et al
    Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer.
    Virol J. 2026 Jan 27. doi: 10.1186/s12985-026-03072.
    Abstract

  355. WAN Y, He Y, Chen X, Wang S, et al
    Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy.
    Cancer Gene Ther. 2026 Jan 27. doi: 10.1038/s41417-025-00958.
    Abstract

  356. VENGHATERI JB, Nathani P, Kaur J, Gadgil A, et al
    India's Path to Cervical Cancer Control: From Obstacles to Opportunities in HPV Vaccine Uptake.
    Public Health Res Pract. 2026 Jan 20:PU25036. doi: 10.1071/PU25036.
    Abstract

  357. WILKINSON AN, Wright K, Savage C, Pearl D, et al
    Towards Cervical Cancer Elimination: Insights from an In-Depth Regional Review of Patients with Cervical Cancer.
    Curr Oncol. 2026;33:52.
    Abstract

  358. NAGDEV P, Chittilla M
    Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018-2025).
    Curr Oncol. 2026;33:48.
    Abstract

  359. XIAO H, Guo F, Wang Z, Pei K, et al
    Is Moderately Hypofractionated Radiotherapy a Safe and Effective Strategy for Cervical Cancer?-A Review of Current Evidence.
    Curr Oncol. 2026;33:24.
    Abstract

  360. ZAMUDIO CANAS R, Vallejo Ruiz V, Jaramillo Flores ME, Delgado Macuil RJ, et al
    Detection of Premalignant Cervical Lesions via Maackia amurensis Lectin-Based Biosensors.
    Biosensors (Basel). 2025;16:24.
    Abstract

  361. LEONI F, Giorgi Rossi P, Morana C, Marchione R, et al
    Conservative Management of CIN2 Within Primary HPV Cervical Cancer Screening Programme: A Cohort Study.
    J Low Genit Tract Dis. 2026 Jan 26. doi: 10.1097/LGT.0000000000000930.
    Abstract

  362. SELVAJOTHI J, Hewitt M, de Haan A, Ting S, et al
    Managing women with cervical cancer symptoms: Cervical One-Stop Assessment Clinic.
    Ir Med J. 2026;119:9.
    Abstract

  363. OMI M, Saito M, Nishino S, Fusegi A, et al
    Case report on critical well-leg compartment syndrome: early diagnosis and treatment after cervical cancer surgery.
    Int Cancer Conf J. 2025;15:25-29.
    Abstract

  364. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study.
    Cancer Med. 2026;15:e71559.
    Abstract

  365. HUANG C, Pang G, Lang X, Zhang J, et al
    Single-Cell RNA Sequencing Analysis Reveals Correlation Between Immune Cell Composition and Gene Expression in Cervical Cancer.
    J Cell Mol Med. 2026;30:e70998.
    Abstract

  366. CHEN L, Liu L, Lin F, Fu Y, et al
    Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study.
    Cancer Med. 2026;15:e71585.
    Abstract

  367. XIAO Y, Zhao Y, Wang Z, Peng C, et al
    Ferroptosis Targeting by beta-Sitosterol in Cervical Cancer Radiotherapy.
    Curr Med Chem. 2026 Jan 19. doi: 10.2174/0109298673409273251103055503.
    Abstract

  368. LI W, Yan Q, Zhou D, Yin X, et al
    Disparities in early-stage cervical cancer detection: the critical role of educational attainment in 75,268 women in Hubei Province.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-025-26056.
    Abstract

  369. SIFERIH M, Gedif G, Lamesgen A, Alamneh AA, et al
    Point-of-care HPV testing for cervical cancer screening in Sub-Saharan Africa: platform diversity, diagnostic performance, implementation feasibility, and determinants-a scoping review with contextual considerations for Ethiopia.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-026-26382.
    Abstract

  370. SAMBATH J, George IA, Manda SS, Ariyannur P, et al
    Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.
    Mol Oncol. 2026 Jan 26. doi: 10.1002/1878-0261.70108.
    Abstract

  371. DE LA CRUZ-HERNANDEZ E, Morales-Sandoval GC, Lizano M, Aviles-Salas A, et al
    Prognostic value of glioma-associated oncogene homolog 1 and SET domain-containing protein 2 immunohistochemical scores in locally advanced cervical cancer.
    Oncol Lett. 2026;31:105.
    Abstract

  372. LIU Y, Wu R, Zhang L
    A cross-sectional study on the quality of cervical cancer health information across multiple short video platforms: Analysis of content, quality, and dissemination characteristics.
    Digit Health. 2026;12:20552076261415927.
    Abstract

  373. GOVENDER S, Phillips TK, Walter FM, Day S, et al
    Cervical cancer awareness among women recently diagnosed with cervical cancer in South Africa and Zimbabwe.
    Ecancermedicalscience. 2025;19:2018.
    Abstract

  374. NARTEY Y, Osae-Larbi J, Daniels J
    Cervical cancer screening in women with disabilities in Ghana: bridging the gap in access and equity.
    AJOG Glob Rep. 2025;6:100597.
    Abstract

  375. JI R, Geng R, Zhang Z, Gao F, et al
    Exploring the Dynamic Changes of Intercellular Connections in Cervical Cancer: Insights From Transcriptomic Data Combined With Single-Cell Sequencing.
    Hum Mutat. 2026;2026:8140041.
    Abstract

  376. GO AE, Feliciano EJG, Martinez J, Ho FDV, et al
    Global determinants of cervical cancer outcomes: a health systems analysis.
    BMJ Oncol. 2026;5:e000975.
    Abstract

  377. SUN Y, Zhang J, Guo L, Zhang J, et al
    Discovering the abnormalities and functional importance of ferroptosis-related molecules in cervical cancer.
    Int J Med Sci. 2026;23:443-460.
    Abstract

  378. YU H, Chen J, Lin J, Chen L, et al
    Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study.
    Front Immunol. 2026;16:1701319.
    Abstract

  379. AMBOREE TL, Dorali P, Damgacioglu H, Montealegre JR, et al
    The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the US.
    JNCI Cancer Spectr. 2026 Jan 25:pkag005. doi: 10.1093.
    Abstract

  380. DANIELS-DONKOR SS, Marryat L
    Health system barriers and facilitators influencing the uptake of cervical cancer screening among women in sub-Saharan Africa: systematic review and meta-synthesis.
    BMC Health Serv Res. 2026 Jan 24. doi: 10.1186/s12913-026-14003.
    Abstract

  381. POLEBOYINA PK, Pawar SC
    Elucidation of MMP-9 expression and association of MMP-9 rs3918242-1562 C/T promoter polymorphism in the progression of cervical cancer.
    Cancer Genet. 2026;302-303:79-92.
    Abstract

  382. ABAR B, Wood N, Merriman J, Adler D, et al
    Test results and follow-up care stemming from an ED-based cervical cancer intervention.
    Am J Emerg Med. 2026;102:78-80.
    Abstract

  383. LI J, Zhong X, Mou Y, Tao X, et al
    Identification of dephosphorylation related genes prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Medicine (Baltimore). 2026;105:e47292.
    Abstract

  384. ZHENG H, Gao M, Xu H, Cai J, et al
    Initial different human papillomavirus infection statuses and subsequent infection risk: a decade-long longitudinal study.
    J Health Popul Nutr. 2025;45:32.
    Abstract

  385. MABIKA-OBANDA AKF, Ambounda Ledaga N, Ngou Milama K, Zang Obame V, et al
    Vaccine-preventable HPV burden and cervical abnormalities in women during 2022-2024 Octobre Rose campaigns in Libreville.
    Nat Commun. 2025;17:1032.
    Abstract

  386. HAHN E, Zakaras JM, Balasubramanian A, Russo A, et al
    Identifying gaps in women's preventive health services for women living with HIV in Vermont.
    Reprod Health. 2025;23:15.
    Abstract

  387. PITAKKARNKUL S, Tangjitgamol S, Sangariyavanich E, Buasom R, et al
    The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
    J Gynecol Oncol. 2026;37:e56.
    Abstract

  388. BRENNAN LP, Hamacher F, Claure LA, Claure Dips AL, et al
    Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.
    Anal Methods. 2026;18:786-799.
    Abstract

  389. TONG Y, Xu L, Sun Y, Lan Y, et al
    Construction of a nomogram model for predicting residual or recurrent cervical intraepithelial neoplasia after the loop electrosurgical excision procedure.
    Am J Clin Pathol. 2026;165:aqaf125.
    Abstract

  390. SHARMA S, Verma M, Rautela I, Khan F, et al
    Tumor Microenvironment: From Cervical Carcinogenesis to Therapeutic Advancements.
    Curr Pharm Biotechnol. 2025;26:2065-2081.
    Abstract

  391. CHEN J, Wu M, Zhang R, Cao Y, et al
    Luteolin, a Bioactive Compound from Celastrus orbiculatus Stem, Inhibits Cervical Cancer via CA2 Suppression: A Translational Study Bridging Basic Research and Clinical Application.
    J Ethnopharmacol. 2026 Feb 4:121326. doi: 10.1016/j.jep.2026.121326.
    Abstract

  392. SMITH MA, Killen J, Jamieson L, O'Farrell X, et al
    Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling study.
    Lancet Public Health. 2026 Feb 3:S2468-2667(26)00005.
    Abstract

  393. ZHANG L, Zhang S, Liu S, Jian W, et al
    Human Papillomavirus Vaccination Policies and Discourse on Social Media.
    JAMA Health Forum. 2026;7:e256425.
    Abstract

  394. FOKOM DOMGUE J, Chandra M, Oladoyin O, Desai M, et al
    Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.
    JAMA Netw Open. 2026;9:e2558841.
    Abstract

  395. LOOS G, Duclos M, Ennequin G
    Physical activity and exercise in cervical cancer: a state-of-the-art review.
    Cancer Causes Control. 2026;37:41.
    Abstract

  396. AGYEMAN AA, Bader G, Opoku NKO
    The impact of human papillomavirus vaccination implementation in reducing cervical cancer in a heterosexual population.
    Cancer Causes Control. 2026;37:42.
    Abstract

  397. PANG S, Jian X, Wei W, Chen Y, et al
    Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical Cancer Assessment.
    Anal Chem. 2026 Feb 6. doi: 10.1021/acs.analchem.5c05791.
    Abstract

  398. JOSTEN K, Rose Dhar R, Reshmi B, Natti Krishna V, et al
    Barriers to HPV vaccination among adolescent girls in India: A scoping review.
    Indian J Med Res. 2026;162:743-753.
    Abstract

  399. CHEPKORIR J, Kivuti-Bitok L, Perrin N, Gross D, et al
    Cervical cancer information access and dissemination strategies among rural Kenyan women: A mixed methods study.
    J Public Health Afr. 2026;17:1457.
    Abstract

  400. OZGURLUK I, Erdem HB, Alay MT, Oktar O, et al
    Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer.
    Oncol Lett. 2026;31:117.
    Abstract

  401. LOU H, Langan D, Syracuse N, Murphy EA, et al
    A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy.
    medRxiv [Preprint]. 2026 Jan 23:2026.01.21.26344562.
    Abstract

  402. RODRIGUEZ NM, Case X, Balian L, Ziolkowski R, et al
    Cervical Cancer Screening Rates and Associated Sociodemographic and Behavioral Factors among People Experiencing Homelessness in Indiana.
    Res Sq [Preprint]. 2026 Jan 30:rs.3.rs-8524257. doi: 10.21203/rs.3.rs-8524257.
    Abstract

  403. WANG Q, Su M, Zheng Y
    The Application of Tumor-Free Technique in Robotic Single-Site Radical Hysterectomy for Early Stage Cervical Cancer.
    Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-025-19026.
    Abstract

  404. YANG J, Shi Z, Song T, Shao Y, et al
    LncRNA TMPO-AS1 aggravates the cisplatin resistance in cervical cancer via miR-140-5p/DNMT1 axis-mediated DNA methylation of KLK10.
    Med Oncol. 2026;43:136.
    Abstract

  405. PENG L, Yu S, Dong Y, Gu H, et al
    A potential association between the characteristics of the multi-organ microbiota and lymph node metastasis in cervical cancer.
    Front Cell Infect Microbiol. 2026;15:1639811.
    Abstract

  406. ZHANG J, Shen J, Yuan L
    Effect of HOXB7 in promoting proliferation, invasion and migration of cervical cancer cells.
    Cytotechnology. 2026;78:38.
    Abstract

  407. ZHANG Y, Yuan J, Chen L
    Transforming cervical cancer pathological diagnosis through artificial intelligence: progress, performance, and barriers to clinical implementation.
    Front Oncol. 2026;15:1716018.
    Abstract

  408. NEWHOUSE R, McWilliams L, Baker-Rand H, Cullimore V, et al
    Investigating the Acceptability of Cervical Screening and Self-Sampling in Postnatal Women at the 6-Week Postnatal Check-Up: A Qualitative Study.
    Health Expect. 2026;29:e70582.
    Abstract

  409. ALLIN T, Taunton C, Ketchell F, Hempenstall A, et al
    High Cervical Cancer Screening Rates and Low Human Papillomavirus Detection in the Remote Torres Strait, Far North Queensland.
    Aust N Z J Obstet Gynaecol. 2026;66:e70060.
    Abstract

  410. TATARNIKOVA I, Talyshev V, Sen'kova A, Markov O, et al
    Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36260.
    Abstract

  411. LEINO A, Numminen E, Kares S, Merio M, et al
    Clinical relevance of partial HPV genotyping in cervical cancer screening.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36594.
    Abstract

  412. TIAN X, Cao C, Wang L, Zhang J, et al
    Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.
    BMJ. 2026;392:e084831.
    Abstract

  413. DOU J, Liu Z
    Mapping interventions to increase uptake of breast and cervical cancer screening along the Intervention Ladder: a systematic review.
    Health Psychol Rev. 2026 Feb 4:1-30. doi: 10.1080/17437199.2026.2623887.
    Abstract

  414. SCHWAB R, Emrich K, Heimes AS, Schwarzer K, et al
    Combined Cervical Cancer Screening and the Incidence of Adenocarcinoma: An Analysis of Data From the German Cancer Registries.
    Dtsch Arztebl Int. 2026;.
    Abstract

  415. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    Abstract

  416. RAJAIE S, Emamgholipour S, Azari S, Karimi Z, et al
    Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.
    Hum Vaccin Immunother. 2026;22:2609345.
    Abstract

  417. SHEN Y, Kang M
    Retrospective analysis of preoperative serum tumor marker levels and their correlation with pathological characteristics and prognosis in cervical cancer patients.
    Front Genet. 2026;17:1724789.
    Abstract

  418. BAHARDOUST M, Ghalavand N, Shamohammadi M, Asl MS, et al
    Pretreatment CRP-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker of Survival and Recurrence-Free Survival in Patients With Early-Stage Cervical Cancer After Radical Hysterectomy: A Multicenter Retrospective Cohort Study.
    Obstet Gynecol Int. 2026;2026:6137796.
    Abstract

  419. WISE J
    Cervical cancer: Fewer screening tests needed, study suggests.
    BMJ. 2026;392:s224.
    Abstract

  420. LU X, Yao L, Xu X, Rexiti MG, et al
    m5c-modified LINC01094 participates in epithelial-mesenchymal transition and metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis.
    Mamm Genome. 2026;37:32.
    Abstract

  421. NING B, Li Z, Yu D, Li C, et al
    Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.
    Phys Imaging Radiat Oncol. 2026;37:100908.
    Abstract

  422. POLANE MG, Dlamini SB
    A qualitative study exploring the primary health care nurses' lived experiences of cervical cancer screening.
    Afr J Prim Health Care Fam Med. 2026;18:e1-e9.
    Abstract

  423. KAYA M, Kara Y, Sanli-Mohamed G
    Anticancer Properties of Newly Synthesized Pyrrole Derivatives as Potential Tyrosine Kinase Inhibitors.
    J Biochem Mol Toxicol. 2026;40:e70665.
    Abstract

  424. JAHANSHAHI S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, et al
    Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.
    Retrovirology. 2026 Feb 2. doi: 10.1186/s12977-025-00672.
    Abstract

  425. AYSI?N N, Kurt Can E, Koltas S, Yilmaz M, et al
    A qualitative study on the experiences of stigmatisation and spiritual coping among women diagnosed with cervical cancer in Turkey.
    BMC Womens Health. 2026 Feb 2. doi: 10.1186/s12905-026-04318.
    Abstract

  426. HARIPRASAD R, Bhatnagar T
    A Systematic Framework for Evaluating Cervical Cancer Screening Programs: Innovative Approaches and Best Practices.
    Indian J Public Health. 2026;70.
    Abstract

  427. MABROUK NOUH F, Abualruz H, Al-Zoubi M, Al-Mugheed K, et al
    Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection.
    Hum Vaccin Immunother. 2026;22:2609329.
    Abstract

  428. XIA W, Wang J, Yang X, Sha Y, et al
    DNA methylation triage of human papillomavirus-positive atypical squamous cells of undetermined significance in cervical cancer screening.
    J Obstet Gynaecol. 2026;46:2623828.
    Abstract

  429. PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
    Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
    Abstract


  430. Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
    Abstract

  431. WENTZENSEN N, Egemen D
    Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
    Abstract

  432. HULLON D, Kara Damor D, Singh T, ALKhatib M, et al
    The Overlay of Cervical Cancer with Cardiac Metastasis.
    Cardiology. 2026 Feb 2:1-22. doi: 10.1159/000550823.
    Abstract

  433. TJALMA WA
    Rare Today, Common Tomorrow: Strengthening Cervical Cancer Prevention in Low-Incidence Countries is Urgently Needed.
    Int J Prev Med. 2025;16:85.
    Abstract

  434. ZRAIDI M, Kamel N, El Belloute G, Abidi K, et al
    [Obstetrical characteristics related to cervical cancer in the Northern Territory of the Rabat-Sale-Kenitra Region, Morocco].
    Pan Afr Med J. 2025;52:102.
    Abstract

  435. ZHANG F, Hu J, Bian J, Lan Y, et al
    Mullerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman: diagnostic challenges and laparoscopic treatment: a case report.
    Pan Afr Med J. 2025;52:110.
    Abstract

  436. WANG R, Liu S, Wang R, Guo Q, et al
    Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer.
    Obstet Gynecol Int. 2026;2026:2210380.
    Abstract

  437. SHEN X, Guo W, Yao C, Wu H, et al
    Epidemiological analysis of human papillomavirus and its subtype infections in 36,248 women in Wuhan, China.
    Front Public Health. 2026;14:1745604.
    Abstract

  438. WANG X, Wang Q, Ding G, Wang J, et al
    Artificial intelligence for colposcopic and cytological image analysis in early cervical cancer detection.
    iScience. 2026;29:114627.
    Abstract

  439. ROTHSCHILD H, Keverline K, McKinney S, Farrell M, et al
    From #cervicalcancerscreening to #LEEP - Quality and accuracy of cervical cancer content on TikTok.
    Gynecol Oncol Rep. 2025;63:102018.
    Abstract

  440. ADANKWAH E, Mensah ABB, Konney T, Nones M, et al
    A pilot study on the acceptability and feasibility of HPV self-sampling for cervical cancer screening among women attending urban hospitals in Kumasi, Ghana.
    J Cancer Policy. 2026 Jan 30:100710. doi: 10.1016/j.jcpo.2026.100710.
    Abstract

  441. GUIDOBALDI L, Cafiero C, Stillitano G, Ricciardi E, et al
    Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular Lesions.
    Infect Disord Drug Targets. 2026.
    Abstract

  442. SHAHRY P, Mohammadi Khoshoei Z, Cheraghi M, Talaiezadeh A, et al
    Population-based epidemiological study of cervical cancer in Khuzestan province, Iran (2014-2019).
    BMC Public Health. 2026 Jan 31. doi: 10.1186/s12889-026-26428.
    Abstract

  443. SABATIER R, Hennequin C, Martin-Babau J, Follana P, et al
    [French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer].
    Bull Cancer. 2026 Jan 30:S0007-4551(26)00022.
    Abstract

  444. PARIDA P, Mehta A, Raj EA, Guruvare S, et al
    Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2026;220:105161.
    Abstract

  445. JIANG N, Xin Z, Zhang Y, Liu Y, et al
    Clinical translation of a DWI-radiomics nomogram integrating serum biomarkers for pretreatment staging of cervical cancer.
    BMC Med Imaging. 2026 Jan 30. doi: 10.1186/s12880-026-02175.
    Abstract

  446. KAIDO Y, Kagabu M, Chiba Y, Sato S, et al
    Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.
    Int J Clin Oncol. 2026 Jan 30. doi: 10.1007/s10147-026-02971.
    Abstract

  447. CHARGARI C, Martinez A, Michels J, Lecuru F, et al
    [French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer].
    Bull Cancer. 2026 Jan 29:S0007-4551(26)00025.
    Abstract

  448. SAGER G, Livik M, Hellevik T, Orbo A, et al
    Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation.
    Anticancer Res. 2026;46:611-618.
    Abstract

  449. YANG ST, Chang CW, Wang PH
    Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix.
    Taiwan J Obstet Gynecol. 2026;65:64-69.
    Abstract

  450. IMATAKE H, Taki M, Yamanoi K, Murakami R, et al
    Healthcare provider bias in cancer treatment decisions for elderly patients.
    Taiwan J Obstet Gynecol. 2026;65:29-33.
    Abstract

  451. NIRMALKAR AP, Mamulwar M, Godbole S, Shahabuddin SM, et al
    Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol.
    BMJ Open. 2026;16:e108752.
    Abstract

  452. PENG Z, Liu C, Tang D, Li S, et al
    Slice-prompted HR-CTV interactive segmentation for cervical cancer brachytherapy: A multi-center study.
    Med Phys. 2026;53:e70305.
    Abstract

  453. ZHOU Z, Li J, Zhao X, Xu H, et al
    Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence.
    Curr Issues Mol Biol. 2026;48:64.
    Abstract

  454. LEI X, Yang W, Xu S, Wu H, et al
    Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:1014.
    Abstract

  455. VIDALINA D, Ghali L, Kassouf N, Li S, et al
    The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:990.
    Abstract

  456. GHOLAMI S, Aghbash PS, Ravanlo ZZ, Rahimi SB, et al
    Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.
    Int Immunopharmacol. 2026;172:116193.
    Abstract

  457. COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
    Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication.
    Vaccine. 2026;74:128223.
    Abstract

  458. XIE X, Liu C, Liu X, Hou L, et al
    Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Sci Rep. 2026;16:5155.
    Abstract

  459. YI H, Huang J, Zhang N, Sundquist J, et al
    The association of post-conization pregnancy with subsequent cervical lesions: evidence from a nationwide cohort in Sweden.
    BMC Med. 2025;24:61.
    Abstract

  460. WANG Z, Hu T, Liu W, Zhou H, et al
    Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types.
    Microbiol Spectr. 2026;14:e0303625.
    Abstract

  461. SHI L, Gao X, Huang L, Gao Z, et al
    Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial.
    BMC Infect Dis. 2025;26:248.
    Abstract

  462. CONTRERAS GARDUNO S, Saraiba-Rabanales V, Chavarri-Guerra Y, Soto-Perez-de-Celis E, et al
    Trends in Cervical Cytology Test Reports and Cervical Dysplasia Severity according to Social Deprivation in Mexico (2013-2019): An Analysis of a National Database.
    Cancer Epidemiol Biomarkers Prev. 2026;35:341-347.
    Abstract

  463. AHADI L, Zarei F, Kazemnejad A
    From screen to screening: a randomized controlled trial on mHealth vs. traditional training on knowledge, attitudes, practice, self-efficacy, and adherence intention to pap smear.
    BMC Womens Health. 2025;26:61.
    Abstract

  464. DALAL S, Sundstrom K, Silva R, Taghavi K, et al
    Age-specific distribution of cervical precancer and cancer among women living with HIV across seven countries: a systematic review and an individual patient data meta-analysis.
    Lancet HIV. 2026;13:e126-e137.
    Abstract

  465. TRAN CT, Wang M, Plymoth M, Chen J, et al
    Accuracy of Self-Reported Cervical Screening Status Among Pregnant Women.
    Aust N Z J Obstet Gynaecol. 2025 Nov 26. doi: 10.1111/ajo.70057.
    Abstract

  466. RUAN J, Gao C, Wang R, Hu B, et al
    A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside.
    Cancer Lett. 2026;640:218110.
    Abstract

  467. ZHANG Z, Kong D, Ding Y, Lu M, et al
    Laser ablation combined with photodynamic therapy for complex vaginal HSIL after repeat cervical conizations: a case report.
    Photodiagnosis Photodyn Ther. 2026;57:105267.
    Abstract

  468. WANG Z, Luo H
    Diagnostic Value of Ultrasound in Primary Cervical Ewing's Sarcoma: Two Case Reports and Literature Review.
    J Clin Ultrasound. 2026;54:490-498.
    Abstract

  469. YANG L, Zou Y, Tian R
    Cervical Paraganglioma Negative on Both 68Ga-DOTATATE and 18F-FDG PET/CT Studies.
    Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005895.
    Abstract

  470. FENG H, Zhao J, Zhang J, Jia P, et al
    The role of E7 oncoprotein self-sampling and self-testing in cervical cancer screening.
    BMC Womens Health. 2026 Feb 16. doi: 10.1186/s12905-026-04336.
    Abstract

  471. DISILVESTRO JB, Scott A, Novetsky AP, Perkins RB, et al
    A Lens into the Quality Standards of Modern-Day Colposcopy.
    Obstet Gynecol Clin North Am. 2026;53:121-138.
    Abstract

  472. ANDERSSON H, Dillner J
    Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer in Sweden.
    Prev Med. 2026 Feb 13:108540. doi: 10.1016/j.ypmed.2026.108540.
    Abstract

  473. ANDERSON EM, Saah AJ, Tota JE
    HPV Type Replacement After HPV Vaccination.
    Curr Top Microbiol Immunol. 2026;448:113-127.
    Abstract

  474. GRIFFIOEN MS, Runello F, Steenbergen RDM
    DNA Methylation in Cervical Intraepithelial Neoplasia and Cervical Cancer: Triage and Management.
    Curr Top Microbiol Immunol. 2026;448:93-112.
    Abstract

  475. DILLNER J
    Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes.
    Curr Top Microbiol Immunol. 2026;448:81-92.
    Abstract

  476. ELLIS LB, Kyrgiou M, Moscicki AB
    Microbiome, Human Papillomavirus and Cervical Carcinogenesis.
    Curr Top Microbiol Immunol. 2026;448:59-80.
    Abstract

  477. DEL PINO M
    Cofactors in Human Papillomavirus Carcinogenesis.
    Curr Top Microbiol Immunol. 2026;448:39-58.
    Abstract

  478. POKA R
    [New data to the evolution of the surgical treatment of early-stage cervical cancer].
    Orv Hetil. 2026;167:251-256.
    Abstract

  479. SHI Y, Yao Y, He F, Chen X, et al
    Association of EGFR and EGF gene polymorphisms with cervical cancer in a case-control study and cross-cancer meta-analysis.
    Sci Rep. 2026 Feb 14. doi: 10.1038/s41598-026-38712.
    Abstract

  480. HE G, Qu X, Ding Z, Liang J, et al
    IGSF3 binds to TNFR2 on Treg to facilitate immunosuppression in cervical cancer.
    Cancer Lett. 2026 Feb 12:218307. doi: 10.1016/j.canlet.2026.218307.
    Abstract

  481. MEI J, Yang Z, Li M, Xiong C, et al
    The impact of illness perception on marital quality among patients with cervical cancer and their husbands: based on actor-partner interdependence mediation model.
    Eur J Oncol Nurs. 2026;81:103143.
    Abstract

  482. JIANG H, Zhu P, Chen Y, Xiong J, et al
    The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High-Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse.
    J Med Virol. 2026;98:e70836.
    Abstract

  483. SWANSON M, El Ayadi A, Nakalembe M, Namugga J, et al
    Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.
    BMC Womens Health. 2026 Feb 13. doi: 10.1186/s12905-026-04292.
    Abstract

  484. COLE G, Ali AA, McCrudden CM, McBride JW, et al
    Corrigendum to "DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system" [Eur. J. Pharm. Biopharm. 127 (2018) 288-297].
    Eur J Pharm Biopharm. 2026 Feb 12:115018. doi: 10.1016/j.ejpb.2026.115018.
    Abstract

  485. LIU X, Wang A, Su M, Liang Z, et al
    ADARB1 inhibits glycolysis and progression of cervical cancer through the HMGB1/PFKFB3 axis.
    Biochim Biophys Acta Mol Basis Dis. 2026 Feb 11:168191.
    Abstract

  486. VINCZE A, Marai D, Frivaldszky L, Rancz A, et al
    Neoadjuvant chemotherapy enables fertility preservation without compromising oncologic outcomes in early cervical cancer >/=2 cm: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2026;52:111461.
    Abstract

  487. GUO Q, Wang H, Diao X, Liu Y, et al
    Utility of PAX1/JAM3 methylation analysis for triage of high-risk HPV-positive individuals.
    Lab Med. 2026;57:lmaf096.
    Abstract

  488. SNIADECKI M, Jaworek P, Regent B, Biernat W, et al
    Challenges in examining mentally Ill virgo intacta: a case of non-HPV cervical cancer and potential ovarian metastasis.
    Ginekol Pol. 2026 Feb 13. doi: 10.5603/gpl.106395.
    Abstract

  489. ZHANG G, Wang L, Chen J, Wang J, et al
    LAG-3-associated CD8(+) T-cell dysfunction in the cervical cancer tumor microenvironment.
    Front Immunol. 2026;17:1750726.
    Abstract

  490. WANG Y, Xie Y, Fang Y, Sui B, et al
    Acupuncture combined with immunotherapy for recurrent and metastatic cervical cancer: a pilot RCT protocol.
    Front Oncol. 2026;16:1718170.
    Abstract

  491. MISHRA V, Pandey L, Pandey A, Chatterjee R, et al
    Evaluation of Interfraction Dose Discrepancies in Organs at Risk, Clinical Target Volume, and Points A and B in Computed Tomography-based High-dose-rate Intracavitary Brachytherapy for Cervical Cancer Patients.
    J Med Phys. 2025;50:709-713.
    Abstract

  492. DETWONGYA C, Tantipalakorn C, Charoenkwan K
    External validation of the SUCCOR Risk score for predicting recurrence in early-stage cervical cancer patients treated with radical hysterectomy.
    J Gynecol Oncol. 2026 Jan 27. doi: 10.3802/jgo.2026.
    Abstract

  493. MOLIKA P, Nittayaboon K, Kerdkumthong K, Navakanitworakul R, et al
    Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids.
    Int J Mol Sci. 2026;27:1575.
    Abstract

  494. SZTUKA M, Jelen A, Krygier A, Szmajda-Krygier D, et al
    The Epidemiology of Human Papillomavirus (HPV) Infections in Poland in the Light of the Nationwide HPV Vaccination Program for Children Aged 12-13 and Updated HPV DNA Detection Guidelines.
    Int J Mol Sci. 2026;27:1434.
    Abstract

  495. OLIVEIRA MHR, Aparicio SL, Silva JACD, Neto DAL, et al
    Barriers to Accessing Cervical Cancer Screening and Treatment in the Amazon Region-A Systematic Review.
    J Clin Med. 2026;15:1206.
    Abstract

  496. JOUYA S, Shahabinia Z, Mazidimoradi A, Allahqoli L, et al
    Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination.
    J Clin Med. 2026;15:1079.
    Abstract

  497. CHODICK G, Strassberg M
    Association Between Human Papillomavirus Vaccination and the Risk of Cervical Cancer and Precancerous Lesions in Israel: A Retrospective Cohort Study.
    J Clin Med. 2026;15:995.
    Abstract

  498. CHANUDOM I, Tharavichitkul E, Laosiritaworn W
    Survival Period Prediction in Cervical Cancer Patients Using the Selective Stacking Technique.
    Healthc Inform Res. 2026;32:38-49.
    Abstract

  499. ZHAO Q, Yang W, Cao L, Chen Y, et al
    Magnesium Ions Promote the Apoptosis of Cervical Cancer Cells through the PI3K/AKT/FoxO1 Pathway.
    Biol Trace Elem Res. 2026 Feb 13. doi: 10.1007/s12011-026-05014.
    Abstract

  500. BONALA SR, Raja SA, Subramanian BV, Balaraju S, et al
    Randomized comparison of tandem-ring versus tandem-ovoid applicators in volume-based brachytherapy for cervical cancer: Dosimetric analysis and early clinical outcomes.
    Brachytherapy. 2026 Feb 11:S1538-4721(25)00373.
    Abstract

  501. JACQUES LJ, Clarkson M, Humphrey PM
    Patient experiences of radiation-induced menopause in cervical cancer: A scoping review.
    Radiography (Lond). 2026;32:103345.
    Abstract

  502. CHEN J, Gu Y, Zheng Y, Gu M, et al
    FTO promotes the cervical cancer progression via regulation of FGF2 expression.
    Ann Med Surg (Lond). 2026;88:1359-1368.
    Abstract

  503. CHENG C, Yang Y, Qu Y
    Investigation of the impact of image-guided radiotherapy selection on image registration results and non-coding RNAs for cervical cancer patients.
    Noncoding RNA Res. 2025;18:87-91.
    Abstract

  504. QIU H, Shi Q, Tang T, Shen K, et al
    Feasibility study of U-Net-based automatic segmentation of pelvic bone marrow for postoperative radiotherapy in cervical cancer.
    Front Oncol. 2026;15:1612984.
    Abstract

  505. BALAMOU C, Zysman K, Rodrigue CM, Seigneurin A, et al
    Impact of commune level social inequalities on time to diagnosis and follow-up in women with high-grade cervical lesions in Isere, France: Evidence from the French cervical cancer screening program.
    Prev Med Rep. 2026;62:103396.
    Abstract

  506. YANG C, Li M, Yang C, Jiang P, et al
    Radiomics based on habitat analysis in predicting parametrial invasion of early stage cervical cancer.
    Front Oncol. 2026;16:1694347.
    Abstract

  507. CORBEAU A, Welters MJP, Boekestijn S, Mens JWM, et al
    Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.
    Clin Transl Radiat Oncol. 2026;58:101107.
    Abstract

  508. LU Y, Zhao J, Jia Z, Zhang C, et al
    Efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
    Transl Cancer Res. 2026;15:17.
    Abstract

  509. WANG C, Zhu K, Bai L, Zhu X, et al
    Sodium selenite promotes apoptosis and augments autophagic flux in cervical cancer cells by activating the YAP-Hippo signaling pathway.
    Transl Cancer Res. 2026;15:36.
    Abstract

  510. MORADPANAH S, Rahimi S, Nayebzadeh M, Doosty F, et al
    Hydrogel-enhanced brachytherapy in cervical cancer: redefining precision, efficacy, and safety.
    Eur J Med Res. 2026 Feb 11. doi: 10.1186/s40001-026-03876.
    Abstract

  511. LIU J, Zhou L, Yao P, Zhang N, et al
    M(5)C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance.
    Cell Death Dis. 2026 Feb 11. doi: 10.1038/s41419-026-08453.
    Abstract

  512. MOODLEY J, Scott SE, Day S, Guzha BT, et al
    Time to diagnosis for breast, cervical and colorectal cancer in Zimbabwe and South Africa: a cross-sectional study.
    BMJ Glob Health. 2026;11:e021889.
    Abstract

  513. CHAE YK, Othus M, Patel SP, Backes FJ, et al
    DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.
    J Immunother Cancer. 2026;14:e012805.
    Abstract

  514. FLINT ML, Byrne ME, Friedman CF
    Locally Advanced Cervical Cancer: What is the Preferred Systemic Treatment?
    J Natl Compr Canc Netw. 2025;23:e257123.
    Abstract

  515. ABU-RUSTUM NR, Campos SM, Amarnath S, Arend R, et al
    Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
    J Natl Compr Canc Netw. 2025;23:549-573.
    Abstract

  516. AKERELE OE, Olanrewaju AK
    Social Media Peer-Driven Communication on Cervical Cancer and HPV Vaccine Among Female Youth in Nigeria.
    J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-025-02817.
    Abstract

  517. SUN P, Fan Z, Li L
    Comment on "Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok".
    J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-026-02834.
    Abstract

  518. SHAO D, Wu P, Jiang H, Wang Z, et al
    Global trends and future projections of cervical cancer burden: an integrated analysis of GBD 2021, UN population and WHO HPV vaccination data.
    Front Public Health. 2026;14:1702186.
    Abstract

  519. WANG F, Pang R, Zhang Y
    Efficacy and safety of neoadjuvant chemotherapy followed by radical surgery vs. radical surgery alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Biomed Rep. 2026;24:40.
    Abstract

  520. SHI H, Huang X, Yu J, Shan W, et al
    Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances.
    Discov Oncol. 2026 Feb 11. doi: 10.1007/s12672-026-04588.
    Abstract

  521. SILVA LGSD, Silva PVS, Chaves MFD, Oliveira NPD, et al
    Spatial distribution of timely treatment for cervical cancer: Socioeconomic inequalities and disparities in healthcare service availability in Brazil.
    Cancer Epidemiol. 2026;101:103010.
    Abstract

  522. QUINTERO-URIBE MP, Benavides-Lozano N, Campino-Alvarado T, Aguirre-Martinez MA, et al
    Role of Self-Sampling Devices for HPV Detection in Cervical Cancer Screening: A Systematic Review.
    J Low Genit Tract Dis. 2026 Feb 10. doi: 10.1097/LGT.0000000000000935.
    Abstract

  523. TIAN X, Li M, Wang Z, Fang T, et al
    Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets.
    J Clin Invest. 2026 Feb 10:e199497. doi: 10.1172/JCI199497.
    Abstract

  524. BAVOR C, Jennett C, Phillips E, Mitchell L, et al
    How would Australian women and people with a cervix like to access self-collection for cervical screening? Screening preferences from a national survey.
    Cancer Causes Control. 2026;37:47.
    Abstract

  525. PASSARELLI GV, Whang SN, Gilbert NM, Hu J, et al
    The vaginal microbiome, papillomavirus infection, and cervical cancer: established associations in search of model systems and mechanistic answers.
    mBio. 2026 Feb 10:e0267725. doi: 10.1128/mbio.02677.
    Abstract

  526. WANG X, Zheng X, Fang Y, Zheng T, et al
    The promoting role of protein arginine methyltransferase 1 in cervical cancer: Mechanisms of angiogenesis and immune evasion.
    Cytojournal. 2025;22:104.
    Abstract

  527. NAMUTUNDU J, Nakalembe M, Nakku-Joloba E, Kiguli J, et al
    Integrating the behavior change wheel and co-design approach in selecting strategies for improving cervical cancer screening literacy among rural women living with HIV in Eastern Uganda.
    BMC Health Serv Res. 2026 Feb 9. doi: 10.1186/s12913-026-14152.
    Abstract

  528. MIN S, Xie L, Wu Y, Bo L, et al
    Efficacy of FOXP3+Treg cells combined with platelet in predicting recurrence of cervical cancer: a retrospective study.
    BMC Womens Health. 2026 Feb 9. doi: 10.1186/s12905-026-04274.
    Abstract

  529. WU H, He C, Liu M, Zhao X, et al
    Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy.
    J Appl Clin Med Phys. 2026;27:e70490.
    Abstract

  530. GGINGO S, Obore S, Musaba M, Wandabwa J, et al
    Factors Associated with Human Papillomavirus Vaccination Uptake Among Adolescent Girls in Uganda.
    Am J Trop Med Hyg. 2025;114:355-359.
    Abstract

  531. GUAN J, Liu H, Li J, Chang Z, et al
    Cervical HPV in central China: regional prevalence, subtypes and pathology.
    J Infect Dev Ctries. 2026;20:129-133.
    Abstract

  532. BAO YH, Chen Y, Xiao ML, Li YA, et al
    Primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical model for predicting lymph node metastasis in early-stage cervical cancer.
    Insights Imaging. 2026;17:38.
    Abstract

  533. WINARTO H, Glenardi G, Habiburrahman M, Kusuma F, et al
    Exploring Knowledge, Attitudes, Practices, and Information-Seeking on HPV Infection and Cervical Cancer Prevention in Rural Indonesia.
    Asian Pac J Cancer Prev. 2026;27:693-704.
    Abstract

  534. DAS D, Sepai HM, Pal SK, Chakraborty BC, et al
    An Altered Ratio of CD4+ and CD8+ T Lymphocytes in Cervical Cancer Tissue and Peripheral Blood as a Predictor of Prognostic Outcome: A Clinicopathological Study.
    Asian Pac J Cancer Prev. 2026;27:643-649.
    Abstract

  535. RAY A, Karmakar A, Maiti M, Banerjee S, et al
    Evaluation of the Diagnostic Accuracy of Cervical Cell Morphologies from Android Device-Captured Cytopathological Microscopic Images through Artificial Intelligence in Mainly Rural or Resource-Constraint Areas of India.
    Asian Pac J Cancer Prev. 2026;27:601-612.
    Abstract

  536. DARTIBALE CB, De Souza MVF, Prado GC, Sant'Ana DMG, et al
    Performance of a New Brazilian Self-Sampling Device for High-Risk Human Papillomavirus Screening.
    Asian Pac J Cancer Prev. 2026;27:405-409.
    Abstract

  537. WANG X, Pan X, Li X, Ding B, et al
    Epithelial Cell-Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration.
    Hum Mutat. 2026;2026:4109928.
    Abstract

  538. ALGHANMI R, Alkhalawi E, Albeladi R, Albeladi S, et al
    Parental Knowledge and Acceptance of HPV Vaccine in Rabigh's School, Saudi Arabia.
    Ann Glob Health. 2026;92:13.
    Abstract

  539. JOHNSON M, Joy TM, Rasheed A, Rose BM, et al
    Cervical Cancer Screening Among Rural Women in Ernakulam District, Kerala: A Cross-Sectional Study.
    Cureus. 2026;18:e100961.
    Abstract

  540. WANG Z, Liu H, Chen X, Zhang F, et al
    Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study.
    Asia Pac J Oncol Nurs. 2026;13:100853.
    Abstract

  541. JIANG K, Shao Y, Wang H, Zhao F, et al
    HPV vaccination willingness and behavior among patients with cervical intraepithelial neoplasia in low-resource areas of Western China: a cross-sectional study.
    Front Public Health. 2026;13:1708917.
    Abstract

  542. JOSEPH EA, Mula M, Mehdi Khan MM, Allen CJ, et al
    Assessing long-term quality of life and survivorship priorities in cervical cancer patients: a social media survey-based study.
    Gynecol Oncol Rep. 2026;63:102031.
    Abstract

  543. WANG H, Xu S, Li S, Lin M, et al
    TMEM121 suppresses cervical cancer cell proliferation and migration via interaction with the ERK pathway.
    Am J Cancer Res. 2026;16:70-87.
    Abstract

  544. NISHIZAWA N, Ishikawa M, Maskey MR, Esumi A, et al
    Circularly polarized light scattering imaging of a cancerous layer creeping under a healthy layer for the diagnosis of early-stage cervical cancer.
    J Biomed Opt. 2026;31:027002.
    Abstract

  545. BEREZOWITZ JD, Fish MC, Mehanna LE, Knicely B, et al
    Tiny plastic, big trouble: how polystyrene nanoparticles impact DNA-damage repair deficient cervical cancer cells.
    Soft Matter. 2026 Feb 9. doi: 10.1039/d5sm01095.
    Abstract

  546. VANAN AG, Hassanzadeh F, Ghorbaninezhad F, Taheri F, et al
    LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review.
    Clin Exp Med. 2026;26:130.
    Abstract

  547. JIT M
    Human papillomavirus, human immunodeficiency virus, and the shared road to cervical cancer elimination.
    J Natl Cancer Inst. 2026 Feb 6:djag017. doi: 10.1093.
    Abstract

  548. WIWEKANANDA IGNA, Malek NANN, Endharti AT, Permatasari HK, et al
    Nab-paclitaxel for the treatment of cervical cancer: a systematic review of clinical safety and effectiveness.
    J Chemother. 2026 Feb 8:1-13. doi: 10.1080/1120009X.2026.2625548.
    Abstract


  549. RETRACTION: Epigallocatechin Gallate in Combination With Eugenol or Amarogentin Shows Synergistic Chemotherapeutic Potential in Cervical Cancer Cell Line.
    J Cell Physiol. 2026;241:e70143.
    Abstract

  550. ZHANG Y, Shao Y, Li X, Zhou D, et al
    SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2.
    Commun Biol. 2026 Feb 7. doi: 10.1038/s42003-026-09678.
    Abstract

  551. XIAO C, Wang L, Xia C, Chan PKS, et al
    HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
    Tumour Virus Res. 2026;21:200339.
    Abstract

  552. WU X, Li Y, Zheng Z, Hu J, et al
    Site-specific propynylation modification of apigeninidin enhances anti-cervical cancer activity by targeting PARP-1.
    Bioorg Chem. 2026;172:109600.
    Abstract

  553. HUANG J, Wu S, Wang X, Lin H, et al
    NIR Triggered Fluorescence Imaging and Synergistic Ablation of Cervical Cancer Using ICG-Loaded CuO Nanoleaves via Photothermal-Augmented ROS Amplification.
    ACS Appl Bio Mater. 2026 Feb 7. doi: 10.1021/acsabm.5c02472.
    Abstract

  554. LIU J, Wang A, Wang G, Jiang S, et al
    Gallium-enriched bimetallic nanomedicine for cervical tumour suppression via bioimaging-guided surgery and highly synergistic reactive oxygen species burst.
    J Colloid Interface Sci. 2026;709:139952.
    Abstract

  555. ZHAO C, Li M, Chen R, Zhao Y, et al
    Comparison of different mRNA testing technologies with HPV DNA testing for predicting ASCUS triage and post-cone excision outcomes: a systematic review and meta-analysis.
    Syst Rev. 2026;15:53.
    Abstract

  556. TAN Y, Huang Q, Zeng J, Wang Y, et al
    Transient receptor potential canonical 3 is required for HPV-induced malignant transformation of cervical epithelial cells.
    Commun Biol. 2026;9:204.
    Abstract

  557. MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
    Performance of a novel, urine-based test for the detection of cervical human papillomavirus infection.
    J Clin Microbiol. 2026;64:e0131825.
    Abstract

  558. MA M, Luo F, Ma B, Liu S, et al
    A Multi-instance Learning Network with Prototype-instance Adversarial Contrastive for Cervix Pathology Grading.
    Med Image Anal. 2026;109:103880.
    Abstract

  559. RAKE C, Davidson EJ, Young A, Maskell A, et al
    The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen Study.
    BJOG. 2026;133:814-822.
    Abstract

  560. LUAN Y, Zhu Y, Sun L, Qin F, et al
    MRI quantitative parameters combined with pathological microvascular characteristics predict lymph node metastasis of cervical squamous cell carcinoma.
    Acta Radiol. 2026;67:188-198.
    Abstract

  561. JIN Q, Zhang X, Yuan J, Fang Q, et al
    Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.
    Ann Surg Oncol. 2026;33:2493-2502.
    Abstract

  562. LA FRINERE-SANDOVAL NQNB, Cubbin C, DiNitto DM
    The Association between Binge Drinking and Mammography and Pap Test Screening by Women's Race and Ethnicity.
    J Womens Health (Larchmt). 2026;35:306-317.
    Abstract

  563. XU R, Liu H, Zhu T, Tang H, et al
    An immunosuppressive tertiary lymphoid structure is associated with adverse prognosis in gastric-type endocervical adenocarcinoma.
    J Natl Cancer Inst. 2026;118:276-288.
    Abstract

  564. HOWARD MF, Fyffe-Freil RC, Pierre CC, Maku HO, et al
    Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferences.
    J Clin Microbiol. 2025 Oct 21:e0076724. doi: 10.1128/jcm.00767.
    Abstract

  565. ZHANG X, Wang J, Ke G, Zhang Y, et al
    Self-management experiences of vaginal toxicities among patients undergoing radical radiotherapy for cervical cancer: a qualitative study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04343.
    Abstract

  566. LAMICHHANE A, Kaphle HP, Neupane N, Baral S, et al
    Factors associated with cervical cancer screening uptake among women aged 30-49 years of Bhanu Municipality, Tanahun, Nepal: a cross-sectional study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04360.
    Abstract

  567. LAAS E, Gaillard T, Fourchotte V, Hotton J, et al
    [Cervical cancer with SHAPE criteria: Conisation before simple hysterectomy].
    Bull Cancer. 2026 Feb 19:S0007-4551(26)00101.
    Abstract

  568. YOUNG AP, O'Dwyer MC, Smith R, Saunders N, et al
    Kennedy v Braidwood Ruling Affects Women and Cervical Cancer Screening.
    J Am Board Fam Med. 2025;38:1113-1116.
    Abstract

  569. LEJEUNE CL, Van Calsteren K, Baert T, Vandecaveye V, et al
    A multidisciplinary management approach to cervical cancer during pregnancy.
    Lancet. 2026 Feb 17:S0140-6736(26)00190-X. doi: 10.1016/S0140-6736(26)00190.
    Abstract

  570. VIDAURRE MENDES S, Kischinhevsky DG, Lopes da Silva J, Dos Santos ALS, et al
    Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.
    JCO Glob Oncol. 2026;12:e2500416.
    Abstract

  571. VEERAVAGU T, Hamdiui N, Stein ML, Al-Rubaie N, et al
    Supporting Informed Decision-Making Regarding Participation in Cervical Cancer Prevention Programs: A Qualitative Study Among Turkish-, Moroccan-, and Syrian-Dutch Women.
    Community Health Equity Res Policy. 2026 Feb 20:2752535X261427045.
    Abstract

  572. ZHONG M, Peitz J, Newman M, Yussuf S, et al
    Novel circRNA signatures in cervical cancer: implications for early detection and screening.
    Biomark Med. 2026 Feb 19:1-10. doi: 10.1080/17520363.2026.2631965.
    Abstract

  573. CHIGBU CO, Dim CC, Eneh SC, Olakunde BO, et al
    Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network.
    BMC Health Serv Res. 2026 Feb 20. doi: 10.1186/s12913-026-14167.
    Abstract

  574. ZHAO X, Huang Y, Lv Q, Wang L, et al
    Awareness of cervical cancer and its correlates among junior high school students in Eastern China: a cross sectional study.
    BMC Public Health. 2026 Feb 20. doi: 10.1186/s12889-026-26748.
    Abstract

  575. ANAND KV, Mishra GA, Suryawanshi VB, Pimple SA, et al
    Experiences with HPV self-sampling in India: advancing cervical cancer prevention and screening.
    BMC Public Health. 2026 Feb 19. doi: 10.1186/s12889-026-26212.
    Abstract

  576. LIN J, Lin M, Lin L, Chen Q, et al
    Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma.
    Crit Rev Immunol. 2026;46:27-43.
    Abstract

  577. ROWLINSON E, Snih SA
    Factors associated with mammogram and Papanicolaou testing among Mexican American older women.
    Womens Health (Lond). 2026;22:17455057261421727.
    Abstract

  578. CHEN J, Mo Z, Pan J, Jia L, et al
    Automated gross tumour volume delineation on T2-weighted magnetic resonance imaging coupled with radiomics for predicting cervical cancer recurrence.
    Eur J Med Res. 2026 Feb 18. doi: 10.1186/s40001-025-03777.
    Abstract

  579. AMUBUOMOMBE PP, Itsura P, Tonui PK, Orang'o EO, et al
    Pregnancy outcomes among women with and without HIV infections who underwent excisional treatment for high-grade cervical intraepithelial neoplasia: a retrospective cohort study in low-resource settings.
    BMJ Open. 2026;16:e105559.
    Abstract

  580. AGUSTI N, Viveros-Carreno D, Wu CF, Iniesta MD, et al
    Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical Cancer.
    Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00081.
    Abstract

  581. RICARDO MG, Alberto MG, Maria HA, Ramos, et al
    PD-L1 expression in cervical cancer tissue is strongly associated with the expression of CD73/TGF-beta1, the percentage of CD8+/PD-1+ T cells and disease progression.
    Immunol Lett. 2026 Feb 16:107150. doi: 10.1016/j.imlet.2026.107150.
    Abstract

  582. ZHANG X, Tao X, Bao K
    Comparative analysis of trends and projections of cervical cancer burden among women aged 20-64 years in China, Japan, and South Korea, 1990-2050.
    Discov Oncol. 2026 Feb 18. doi: 10.1007/s12672-026-04688.
    Abstract

  583. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    Abstract

  584. CHENG X, Wang J, Wang H, Song H, et al
    Case Report: A rare case of external iliac artery rupture and sigmoid fistula following multimodal treatment for cervical cancer.
    Front Oncol. 2026;16:1708443.
    Abstract

  585. GOMES P, de Abreu WC, Dos Reis RG, Guerra ENS, et al
    Photobiomodulation therapy approach to a rare phenomenon of radiation recall reaction triggered by cisplatin in a cervical cancer patient: a case report and scoping review.
    Front Oncol. 2026;15:1700942.
    Abstract

  586. THARAVICHITKUL E, Chitapanarux I, Sripan P, Tovanabutra C, et al
    Unlocking economic gains: the impact of image-guided brachytherapy on cervical cancer treatment in Thailand.
    Front Public Health. 2026;13:1725415.
    Abstract

  587. MENG X, Wang Z, Zhang Y, Wang X, et al
    RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study.
    J Appl Clin Med Phys. 2026;27:e70506.
    Abstract

  588. WENTZENSEN N, Egemen D, Clarke MA, Poitras N, et al
    Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping.
    J Clin Oncol. 2026 Feb 17:JCO2500689. doi: 10.1200/JCO-25-00689.
    Abstract

  589. OGUNDARE OC, Adeyemo GO, Folorunsho S
    Determinants of cervical cancer screening among African and African American women: a qualitative systematic review.
    Ethn Health. 2026 Feb 17:1-16. doi: 10.1080/13557858.2026.2630820.
    Abstract

  590. LIU Y, Wang S, Gao S
    Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low-Grade, and High-Grade Squamous Intraepithelial Lesions in Women Under 25 Years Old From the Largest Women Hospital in China.
    J Med Virol. 2026;98:e70846.
    Abstract

  591. WANG Z, Wang Z, Jiang J, Yang L, et al
    Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy.
    Mol Cancer. 2026 Feb 17. doi: 10.1186/s12943-026-02600.
    Abstract

  592. SOLTANI LF, Addis I, Lin P, Kamdar N, et al
    Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection.
    J Am Board Fam Med. 2026 Feb 16. doi: 10.3122/jabfm.2025.250040.
    Abstract

  593. YANG Q, Zhao J, Liu X, Liu J, et al
    Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer.
    Discov Oncol. 2026 Feb 16. doi: 10.1007/s12672-026-04683.
    Abstract

  594. LI Y, Wang F, Fang Z, Sun H, et al
    MUL1 suppresses cervical cancer progression by targeting FUNDC1 for ubiquitination and inhibiting DRP1-dependent mitophagy.
    J Mol Histol. 2026;57:79.
    Abstract

  595. ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al
    Retraction Note: Alternative use of Droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.
    Med Oncol. 2026;43:150.
    Abstract

  596. SINGH A, Sahani P, Singh S, Ojha A, et al
    Role of human papillomavirus (HPV) variants and host genetic susceptibility in cervical carcinogenesis.
    Arch Microbiol. 2026;208:198.
    Abstract

  597. WANG B, Xiao J, Ding Y, Yu J, et al
    Preoperative prediction of parametrial invasion in early-stage cervical cancer: a radiomics nomogram fusing multi-parametric MRI and clinical biomarkers.
    Abdom Radiol (NY). 2026 Feb 16. doi: 10.1007/s00261-025-05353.
    Abstract

  598. KIBONIRE RA, Mphuthi DD
    Understanding the determinants of cervical cancer screening uptake in Hoima District, Uganda.
    Afr J Reprod Health. 2026;30:104-113.
    Abstract

  599. LI D
    Influence of gemcitabine combined with lobaplatin interventional embolization on vaginal flora and biofilm formation in patients with advanced cervical cancer.
    Afr J Reprod Health. 2026;30:38-50.
    Abstract

  600. WANG Z, Zhang Y, Xiu Y, Chen Z, et al
    Au-PtNPs@Mn(3)O(4) Nanozymes Enhance the Antitumor Effect of Photodynamic Therapy and Radiotherapy in Cervical Cancer by Modulating Tumor Hypoxia.
    ACS Omega. 2026;11:8183-8196.
    Abstract

  601. YORKE AA, Muramuzi A, Lin LL, Awusa K, et al
    Quantifying cervical cancer radiotherapy care gap: Baseline assessment prior to implementation of a digital Health App.
    Tech Innov Patient Support Radiat Oncol. 2026;37:100381.
    Abstract

  602. RAY S, Nagar A
    Educational intervention and its effect on medical students' knowledge and readiness for cervical cancer screening and human papillomavirus vaccination.
    J Family Community Med. 2026;33:53-54.
    Abstract

  603. WANG X, Xiong D, Duan B, Huang Y, et al
    Mechanistic pathways predictive modeling and translational interventions for radiation enteritis in cervical cancer radiotherapy.
    Front Cell Infect Microbiol. 2026;15:1729528.
    Abstract

  604. MUNE G, Asefa A, Chillo SL, Woldesemayat EM, et al
    Cervical Cancer Screening and Associated Factors Among Women of Reproductive Age in Sidama Regional State of Ethiopia: A Cross-Sectional Survey.
    Cancer Rep (Hoboken). 2026;9:e70498.
    Abstract

  605. ZHANG T, Choon Park D, Jeong Jeong Y, Geun Yeo S, et al
    Screening of cervical intraepithelial neoplasia based on multiple features extracted from multi-electrode bioimpedance spectroscopy.
    Physiol Meas. 2026;47.
    Abstract

  606. POPOVIC J, Hahut A, Torres GE, Vincent A, et al
    Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain.
    Sci Rep. 2026;16:6797.
    Abstract

  607. LI X, Sun L, Qiu M, Wu X, et al
    Investigation of thoracico-abdominal infrared thermal imaging characteristics in patients with cervical HR-HPV infection.
    Sci Rep. 2026;16:6500.
    Abstract

  608. STUART R, Theopold N, Miall N, Kobayashi E, et al
    The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints.
    Vaccine. 2026;75:128187.
    Abstract

  609. ZOU R, Xu J, Fang Q, Guan R, et al
    A novel cervical image recognition framework based on feature cognitive enhancement for improved performance.
    Proc Inst Mech Eng H. 2026;240:192-205.
    Abstract

  610. CHEN Q, Quan J, Zhu K, Lan L, et al
    Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years.
    Nat Commun. 2026;17:1677.
    Abstract

  611. XIA D, Gao Z, Li J, Chen C, et al
    pH-Responsive Biomineralized Probiotic for Self-Amplifying Mucosal Vaccination: Gut-Engineered Antigen Factories Drive Targeted Cervical Tumor Regression.
    Adv Mater. 2026;38:e10404.
    Abstract

  612. KOIVISTO T, Kalliala I, Eriksson T, Nieminen P, et al
    Human papillomavirus vaccinations' impact on preterm birth rates.
    Eur J Public Health. 2026;36:214-219.
    Abstract

  613. MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
    Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
    J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
    Abstract

  614. CULLIMORE V, Newhouse R, Baker-Rand H, Chu K, et al
    Investigating the acceptability of cervical screening, using conventional clinician-taken cervical samples or urine self-sampling, at 6 weeks postnatal: A cross-sectional questionnaire.
    J Med Screen. 2026;33:48-58.
    Abstract

  615. FITZPATRICK P, O'Flynn A, Jalal R, Frazer K, et al
    Identifying barriers and facilitators to participation in cancer screening among Irish travellers, a minority ethnic group in Ireland, using a codesigned approach.
    J Med Screen. 2026;33:9-14.
    Abstract

  616. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial.
    J Med Screen. 2026;33:62-65.
    Abstract

  617. GAO J, Yang R, Lu R, Ma X, et al
    Current status and influencing factors of different dimensions of HPV knowledge among HPV-infected women.
    J Health Psychol. 2026;31:536-549.
    Abstract

  618. KANG M, Jiang S, Chen H, Xu Y, et al
    Prediction of the Prognosis and Treatment Responses Based on the Characteristics of Disulfidptosis-Related Genes in Patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Endocr Metab Immune Disord Drug Targets. 2026;26:e18715303374396.
    Abstract

  619. HARINATH L, Bai X, Minkowitz J, Zeng X, et al
    Artificial Intelligence in Gynecologic Cytology.
    Acta Cytol. 2026;70:52-71.
    Abstract

  620. KHOLOVA I
    Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.
    Acta Cytol. 2026;70:72-83.
    Abstract

  621. EDVARDSSON H, Dillner J
    Human Papillomavirus Primary Screening and Collaboration in Quality Assurance Work between Laboratories.
    Acta Cytol. 2026;70:46-51.
    Abstract

  622. LONGATTO-FILHO A, Schmitt FC
    Ongoing Challenges in Maintaining the Diagnostic Quality of Cervical Cytopathology: Is It Possible to Minimize Differences in Morphological Interpretations?
    Acta Cytol. 2026;70:40-45.
    Abstract

  623. EBNER C, Purtscheller R, Feroz B, Rieker J, et al
    Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
    Acta Obstet Gynecol Scand. 2025 Dec 21. doi: 10.1111/aogs.70106.
    Abstract

  624. KNUDSEN AS, Randrup TH, Kesmodel US, Booth BB, et al
    Negative margins and negative HPV tests after large loop excision of the transformation zone: A nationwide historical cohort study.
    Acta Obstet Gynecol Scand. 2026;105:186-194.
    Abstract

  625. ERIKSEN DO, Krog L, Ostenfeld EB, Jensen PT, et al
    HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression.
    Acta Obstet Gynecol Scand. 2026;105:377-385.
    Abstract

  626. KALLIALA I, Milerad H, Trope AEC, Hammer A, et al
    Why do the Nordic countries allow colposcopy to be a weak link in the cervical cancer screening chain?
    Acta Obstet Gynecol Scand. 2026 Feb 17. doi: 10.1111/aogs.70166.
    Abstract

  627. WANG M, Fan J, Mu B, Zeng Y, et al
    HDAC5 stabilization by tubeimoside I suppresses cervical cancer metastasis via inhibiting H3K27ac/KPNA2 axis.
    Br J Cancer. 2026 Jan 8. doi: 10.1038/s41416-025-03328.
    Abstract

  628. BOWDEN SJ, Ellis LB, Cuming T, Brogden D, et al
    Multizonal intraepithelial neoplasia of the lower genital tract and anus in women: terminology for defining the disease, an introduction by the British Society for Colposcopy and Cervical Pathology (BSCCP), International Anal Neoplasia Society (IANS),
    Br J Cancer. 2026;134:177-184.
    Abstract

  629. LAWRENCE L
    Adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate-risk, early cervical cancer: Chemoradiation has become the standard of care for patients with locally advanced cervical cancer as well as high-risk featu
    Cancer. 2026;132:e70207.
    Abstract

  630. TAMRAKAR VK, Sharma K, Singh P, Bhargava A, et al
    Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target.
    Cancer. 2026;132:e70292.
    Abstract

  631. BONLOKKE S, Stougaard M, Sorensen BS, Parner E, et al
    Ultrasensitive next-generation sequencing-based detection of circulating human papillomavirus DNA for cervical cancer recurrence monitoring.
    Cancer. 2026;132:e70282.
    Abstract

  632. TERZIOGLU HG, Aragao A, Barroeta JE
    "Atypical Glandular Cells" on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow-Up.
    Diagn Cytopathol. 2026;54:71-77.
    Abstract

  633. OZDEMIR CY, Marangoz B, Ozdemir N, Cicekli N, et al
    Clinical Outcomes and Risk Implications of HPV 31 Infection: A 10-Year Retrospective Cohort Study.
    Diagn Cytopathol. 2026;54:167-172.
    Abstract

  634. HARINATH L, Matsko J, Colaizzi A, Elishaev E, et al
    Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study.
    Diagn Cytopathol. 2026;54:173-183.
    Abstract

  635. LUO MY, Williams CYK
    Application and validation of AI-driven methods to explore patient experiences of pre-cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114953.
    Abstract

  636. CHATTERJEE R, Nobbenhuis M, Kasius J, Kaur M, et al
    Robotic indocyanine green-guided sentinel lymph node mapping in early-stage cervical cancer: The fluorescent robotic indocyanine endoscopic node detection series (FRIENDS).
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114927.
    Abstract

  637. ANAND A, Mala YM, Tyagi S, Sharma P, et al
    Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114945.
    Abstract

  638. TANG W, Wang L, Li X, Yan X, et al
    Radiation-induced acquired expression of PD-L1 and reprogramming of the tumor microenvironment in cervical cancer.
    Gynecol Oncol. 2026;205:17-26.
    Abstract

  639. KIM SI, Kim JW, Kwon JS, Ferguson SE, et al
    Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
    Gynecol Oncol. 2026;205:37-45.
    Abstract

  640. NISHA M, Liang YL, Bateson D, Saville M, et al
    Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program.
    Gynecol Oncol. 2025;204:133-142.
    Abstract

  641. FAN KY, Chehade R, Wang AY, Sachdeva A, et al
    Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis.
    Gynecol Oncol. 2026;204:118-123.
    Abstract

  642. DAIX-MOREUX M, El Hajj H, Scherier S, Deandreis D, et al
    Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
    Gynecol Oncol. 2026;206:99-105.
    Abstract

  643. PALMER TJ, Kavanagh K, Cuschieri K, Cameron RL, et al
    Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening.
    Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70183.
    Abstract

  644. KALJOUW S, Jansen EEL, Olthof EMG, Hontelez JAC, et al
    Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.
    Int J Cancer. 2026;158:1361-1369.
    Abstract

  645. CUI J, Mukherjee A, Patel PG, Junkins A, et al
    Sex and organ-specific risk and temporal trends of human papillomavirus-associated anogenital cancer among solid organ transplant recipients in the United States.
    Int J Cancer. 2026;158:1507-1516.
    Abstract

  646. REDL E, Herzog C, Vavourakis C, Barrett J, et al
    The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.
    Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70354.
    Abstract

  647. KROON KR, Bogaards JA, Berkhof J
    Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.
    Int J Cancer. 2026 Jan 28. doi: 10.1002/ijc.70344.
    Abstract

  648. GIES S, Pohlers M, Tanzer T, Ampofo E, et al
    Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70340.
    Abstract

  649. NOMM O, Innos K, Jasilionis D, Krumins J, et al
    Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register-based study 2000-2015.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70339.
    Abstract

  650. RASMUSSEN RMW, Munk C, Kjaer SK
    Is the beneficial effect of multi-cohort HPV vaccination on cervical cancer and precancerous lesions seen across all educational levels?
    Int J Cancer. 2026 Feb 6. doi: 10.1002/ijc.70360.
    Abstract

  651. DE CARVALHO TM, Berkhof J, Bogaards JA
    Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage.
    Int J Cancer. 2026 Feb 9. doi: 10.1002/ijc.70377.
    Abstract

  652. SNELLMAN J, Pankakoski M, Heinavaara S, Partanen VM, et al
    Increased cervical cancer incidence in the target age of screening-Variation by mode of detection.
    Int J Cancer. 2026 Feb 7. doi: 10.1002/ijc.70371.
    Abstract

  653. IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
    Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
    Int J Gynaecol Obstet. 2026;172:373-382.
    Abstract

  654. PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
    Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
    Abstract

  655. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    Abstract

  656. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    Abstract

  657. DUQUE CAB, Bach RB, Fleider L, Sanchez-Diaz E, et al
    Colposcopists' practice patterns in Latin America: An international cross-sectional survey.
    Int J Gynaecol Obstet. 2026;172:808-814.
    Abstract

  658. ZHANG H, Dai Y, Zhou H, Yang Y, et al
    Application of P16/Ki-67 dual-staining for the detection of high-grade cervical lesions in the triage of patients with minor abnormal cytology: A meta-analysis.
    Int J Gynaecol Obstet. 2026;172:815-827.
    Abstract

  659. MUSA MS, Swai P, Oneko O, Mmbaga B, et al
    Three-year survival rate and associated factors among women with invasive cervical cancer attended at ocean road cancer institute, Tanzania.
    Int J Gynaecol Obstet. 2026 Jan 22. doi: 10.1002/ijgo.70831.
    Abstract

  660. HOFFMANN S, Trif L, Kramer B, Neis F, et al
    PelviSound L-Real-time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop-in probe in endometrial and cervical cancer during minimally invasive surgery: A single-center pilot feasibility study in 20 patients.
    Int J Gynaecol Obstet. 2026 Jan 29. doi: 10.1002/ijgo.70838.
    Abstract

  661. MATSUO K, Matsuzaki S, Roman LD
    Response to "Correspondence on 'Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer' by Matsuo et al" by Hu Y and Fang Q.
    Int J Gynecol Cancer. 2025 Dec 5:102840. doi: 10.1016/j.ijgc.2025.102840.
    Abstract

  662. XU Q, Han J
    Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 5:102846. doi: 10.1016/j.ijgc.2025.102846.
    Abstract

  663. SONG Y, Ran G, Zeng R, Chen C, et al
    Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study.
    Int J Gynecol Cancer. 2025;36:102851.
    Abstract

  664. HU Y, Fang Q
    Correspondence on "Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025 Nov 26:102831. doi: 10.1016/j.ijgc.2025.102831.
    Abstract

  665. WANG K, Zhai Q, Xie Y, Tian Y, et al
    Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer.
    Int J Gynecol Cancer. 2025;36:102881.
    Abstract

  666. CIANCIA M, Mascilini F, Moro F, Testa AC, et al
    Response to the Correspondence by Xu et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 18:102882. doi: 10.1016/j.ijgc.2025.102882.
    Abstract

  667. WU Q, Qiu X, Peng R
    Correspondence on "Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study" by Xiao Shang et al.
    Int J Gynecol Cancer. 2025 Dec 16:102873. doi: 10.1016/j.ijgc.2025.102873.
    Abstract

  668. CIBULA D, Mburu A, Planchamp F, Zapardiel I, et al
    European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer.
    Int J Gynecol Cancer. 2026;36:102747.
    Abstract

  669. LEE SS, Banson K, Koduru H, Berger AA, et al
    Factors associated with treatment delay for cervical cancer patients treated with definitive chemoradiation and brachytherapy.
    Int J Gynecol Cancer. 2026;36:102774.
    Abstract

  670. TORIGOE R, Dennen C, Mayadev J, Makale MT, et al
    Current challenges in the assessment and management of radiotherapy-induced vaginal stenosis.
    Int J Gynecol Cancer. 2026;36:102801.
    Abstract

  671. MARUCCI DA SILVA GF, Pilger TL, Candido Dos Reis FJ
    Incidence of urologic co-morbidities after abdominal radical hysterectomy: a systematic review of clinical trials.
    Int J Gynecol Cancer. 2026;36:102722.
    Abstract

  672. WILLIAMS G, Bindra A, Fink D, Weintraub MR, et al
    Survival in human papillomavirus and non-human papillomavirus-associated invasive endocervical adenocarcinoma: outcomes in a large, integrated healthcare system.
    Int J Gynecol Cancer. 2026;36:102683.
    Abstract

  673. CASARIN J, Meschini T, Schivardi G, Giudici A, et al
    Determinants of adjuvant radiotherapy in early-stage cervical cancer: a retrospective analysis of the SUCCOR cohort.
    Int J Gynecol Cancer. 2025;36:104448.
    Abstract

  674. LEVIN G, Leung SOA
    Correspondence on "Multicenter validated machine learning model for cervical cancer based on HPV genotyping results" by Ziren Chen et al.
    Int J Gynecol Cancer. 2025 Dec 23:104447. doi: 10.1016/j.ijgc.2025.104447.
    Abstract

  675. PENG R, Wu Q, Qiu X
    Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study"(1) by Mascilini et al.
    Int J Gynecol Cancer. 2026 Jan 3:104459. doi: 10.1016/j.ijgc.2025.104459.
    Abstract

  676. CHU R, Wang Z, Shi S, Wu N, et al
    Histology-specific prognostic models for early-stage cervical cancer based on pathologic intermediate-risk factors: a multi-center retrospective study.
    Int J Gynecol Cancer. 2026;36:104465.
    Abstract

  677. CHILINDA G, Moro F, Rijken MJ, Ciancia M, et al
    Ultrasound-based preoperative assessment for cervical cancer: a pragmatic staging and treatment-planning strategy adaptable to diverse resource settings.
    Int J Gynecol Cancer. 2025;36:102885.
    Abstract

  678. HSU HN, Lin YH
    Pembrolizumab-induced vasculitis-like dermatitis in cervical cancer.
    Int J Gynecol Cancer. 2025 Dec 22:104445. doi: 10.1016/j.ijgc.2025.104445.
    Abstract

  679. HU Y, Cheng H, Chen J, Chen S, et al
    Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial.
    Int J Gynecol Cancer. 2026 Jan 5:104457. doi: 10.1016/j.ijgc.2025.104457.
    Abstract

  680. SEO JH, Chung YE, Lim S, Kim SY, et al
    Pre-diagnostic physical activity and mortality in cervical cancer: a nationwide cohort study.
    Int J Gynecol Cancer. 2026 Jan 16:104477. doi: 10.1016/j.ijgc.2026.104477.
    Abstract

  681. CIANCIA M, Moro F, Mascilini F, Testa AC, et al
    Response to the Correspondence by Peng et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2026 Jan 18:104499. doi: 10.1016/j.ijgc.2026.104499.
    Abstract

  682. YONEMORI K, Nishio S, Suzuki S, Hasegawa K, et al
    Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.
    Int J Gynecol Cancer. 2025 Dec 31:104450. doi: 10.1016/j.ijgc.2025.104450.
    Abstract

  683. HEMIDA R, Barakat R, Nabil H, Hasan M, et al
    Retraction notice to "Cervical cancer elimination in low-resource countries: low-cost strategy" [International Journal of Gynecological Cancer, Volume 35 Issue 9 (2025) 101828].
    Int J Gynecol Cancer. 2026;36:104540.
    Abstract

  684. ELMEHRATH AO, Njala B, Sakala D, Nogueras-Gonzalez GM, et al
    Demographic and social determinants of human immunodeficiency virus status among women with cervical cancer in a low-resource setting.
    Int J Gynecol Cancer. 2025 Dec 26:102867. doi: 10.1016/j.ijgc.2025.102867.
    Abstract

  685. SARDINHA TG, Vale DB, Discacciati MG, Triglia RM, et al
    Diagnostic performance and clinical utility of p16 immunostaining in a population-based HPV DNA screening program.
    Int J Gynecol Cancer. 2026;36:104451.
    Abstract

  686. O'SHEA J, Yu K, Chang D, Khaw P, et al
    Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy.
    Int J Gynecol Cancer. 2026;36:102874.
    Abstract

  687. KOBAYASHI M, Yao JA, Lee MW, Nakagawa S, et al
    Relative survival of large cell to small cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2026;36:102852.
    Abstract

  688. SHI J, Du H
    Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study" by Zhou et al.
    Int J Gynecol Cancer. 2026 Jan 20:104505. doi: 10.1016/j.ijgc.2026.104505.
    Abstract

  689. EBRAHIMOGHLI R, Agaei MH, Hakimi MH, Moradoghli F, et al
    Temporal trends and sources of variation in late-stage cervical cancer diagnosis in low- and middle-income countries: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2026 Jan 28:104479. doi: 10.1016/j.ijgc.2026.104479.
    Abstract

  690. WANG L, Wei Y, Wu Q
    Correspondence on "Identifying possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025;35:102710.
    Abstract

  691. NAGAR A, Samanta A, Chopra S, Mittal P, et al
    CT vs. MRI for image-guided brachytherapy in locally advanced cervical cancer: A Propensity Score Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2026 Feb 13:S0360-3016(26)00379.
    Abstract

  692. SMITH EE, Heintz JR, Chesnokova A, Taunk NK, et al
    Improving treatment of radiation-induced premature ovarian insufficiency after cervical cancer: A practice quality improvement initiative.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00389.
    Abstract

  693. CUSCHIERI K, Latsuzbaia A, McMahon H, Giubbi C, et al
    Clinical performance assessment of the Papilloplex HR-HPV assay on self-taken urine and vaginal swab samples: findings from a multicentre European study.
    J Clin Pathol. 2025 Nov 7:jcp-2025-210211. doi: 10.1136/jcp-2025-210211.
    Abstract

  694. ALMAS S, Karki S, Carpenter RE, Tamrakar VK, et al
    Peptide-assisted direct detection of HPV nucleic acids from liquid-based cytology samples without extraction.
    J Clin Virol. 2026;182:105901.
    Abstract

  695. SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
    Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
    Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
    Abstract

  696. YANG XL, Zhu JW, Wang C, Zhou YC, et al
    Radiation- versus surgery-based treatment for patients with resectable IIIC1 cervical adenocarcinoma.
    Radiother Oncol. 2026;216:111370.
    Abstract

  697. CORBEAU A, Spampinato S, Charnalia M, Ranjan N, et al
    Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
    Radiother Oncol. 2026;218:111444.
    Abstract

  698. GAN S, Tang J, Qin S, Ou Q, et al
    Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
    Abstract

  699. HAN X, Di R, Zhang H, Zhou B, et al
    Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
    Abstract

  700. KANG Y, Chang L, Lin H, Liu J, et al
    Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
    Abstract

  701. WANG Y, Deng Y, Wei Y, Wang C, et al
    Association of SMAD4 gene polymorphisms with human papillomavirus infection and risk of cervical cancer: a case-control study.
    BMC Cancer. 2026 Jan 14. doi: 10.1186/s12885-026-15552.
    Abstract

  702. GUO W, Jian W, Zhu L, Zhang B, et al
    3D transformer-based dose prediction in HDR brachytherapy for cervical cancer.
    BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-026-15592.
    Abstract

  703. LIN S, Zhong J, Yuan S, Su M, et al
    Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.
    BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15636.
    Abstract

  704. YANG XL, He JL, Wang TJ, Ran L, et al
    Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
    BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15661.
    Abstract

  705. FEI C, Chen W, Liu J, Wang J, et al
    A real-world multicenter study on opportunistic cervical cancer screening in hospital in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions.
    BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
    Abstract

  706. WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
    Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
    BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
    Abstract

  707. ANENA S, Okello MO, Ouma RC, Olum R, et al
    Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
    Abstract

  708. QIU L, Xie Y, Li Y, Huang J, et al
    Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
    PLoS One. 2026;21:e0339001.
    Abstract

  709. HU J, Wang Y, Liu Y, Cai Z, et al
    Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034.
    PLoS One. 2026;21:e0339923.
    Abstract

  710. TANIOKA M, Nagao S, Ida N, Tanaka Y, et al
    Fertility-sparing surgery with neoadjuvant chemotherapy in early and locally advanced cervical cancer: A clinical protocol.
    PLoS One. 2026;21:e0340963.
    Abstract

  711. WANZALA J, Anino CO
    Uptake of cervical cancer screening and its associated factors among women of reproductive age in Kericho County.
    PLoS One. 2026;21:e0328614.
    Abstract

  712. PROIETTI A, De Angelis E, Buccini L, Leopizzi M, et al
    A pilot multimodal study of cervical cancer: Raman spectroscopy as a molecular fingerprint tool.
    PLoS One. 2026;21:e0327286.
    Abstract

  713. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
    Concurrent depression and anxiety in women undergoing additional diagnostic procedures due to positive screening for cervical cancer.
    PLoS One. 2026;21:e0342492.
    Abstract

  714. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
    Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
    PLoS One. 2026;21:e0341888.
    Abstract

  715. KIM WJ, Kim YW
    Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study.
    PLoS One. 2026;21:e0341660.
    Abstract


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;